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FSP Section 21,000
CHECKLISTS AND ILLUSTRATIVE 
FINANCIAL STATEMENTS FOR HEALTH 
CARE PROVIDERS
.01 The checklists and illustrative financial statements included in this section have been developed by the 
staff of the Technical Information Division of the AICPA as nonauthoritative technical practice aids. Readers 
should be aware of the following:
• The checklists and illustrative financial statements are "tools" and in no way represent official positions 
or pronouncements of the AICPA.
• The checklists and illustrative financial statements have been updated through FASB Statement No. 115, 
FASB Interpretation No. 40, FASB Technical Bulletin No. 94-1, AICPA Statement of Position No. 93-8, 
AICPA Statement on Auditing Standards No. 72, AICPA Statement on Standards for Accounting and 
Review Services No. 7, and AICPA Audit and Accounting Guide, Audits of Providers of Health Care 
Services (with conforming changes as of May 1, 1993). The illustrative financial statements do not 
include disclosures for FASB Statement Nos. 106, 107, 112, 114 or 115. The checklists and illustrative 
financial statements should be modified, as appropriate, for subsequent pronouncements. In determining 
the applicability of a pronouncement, its effective date should also be considered.
• In June 1993, the FASB issued Statements of Financial Accounting Standards (SFAS) No. 116, Account­
ing for Contributions Received and Contributions Made, and No. 117, Financial Statements of Not-for- 
Profit Organizations. SFAS No. 116 changes the accounting for contributions as presently set forth in 
SOP 78-10 and in the audits of Providers of Health Care Services Guide. SFAS No. 117 establishes 
standards for not-for-profit organizations general purpose external financial statements. SFAS Nos. 116 
and 117 are effective for financial statements issued for fiscal years beginning after December 15, 1994, 
except for organizations with less than $5 million in total assets and less than $1 million in annual 
expenses. For those organizations, the Statements are effective for fiscal years beginning after December 
15, 1995. Earlier application is encouraged.
• These Statements are not reflected in these checklists and illustrative financial statements as few 
organizations have adopted these pronouncements at this time. The 1995 edition of these checklists and 
illustrative financial statements will be revised to reflect these new pronouncements. Practitioners whose 
clients have adopted SFAS Nos. 116 and 117 early should determine the effect of these Statements when 
using these checklists and illustrative financial statements.
• The checklists and illustrative financial statements should be used by, or under the supervision of, 
persons having adequate technical training and proficiency in the application of generally accepted 
accounting principles, generally accepted auditing standards, and statements on standards for accounting 
and review services.
• The checklists and illustrative financial statements do not represent minimum requirements and do not 
purport to be all-inclusive. The referenced standards should be reviewed if clarification is needed to 
determine whether the disclosure indicated is required or suggested, and to what extent each disclosure 
is relevant to the statements being presented.
.02 Users of the checklists and illustrative financial statements are urged to refer directly to applicable 
authoritative pronouncements when appropriate. If you have further questions, call the AICPA Technical Hotline.
Note: This publication was extracted from sections 21,000 to 21,600 of the AICPA Financial Statement Preparation Manual (FSP).
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FSP Section 21,100
Introduction
.01 Health care costs, as well as the number of people requiring health care services, have consistently risen. 
As a result, many health care providers are relying more heavily on debt financing to meet capital needs creating a 
greater need for accountability to creditors and investors.
.02 Health care entities may be classified by sponsorship or legal structure within three broad categories: 
voluntary (not-for-profit), governmental, and investor- (or operator-) owned.
Voluntary (not-for-profit): an entity that operates under the direction of governing boards. Usually 
exempt from federal and state income taxes if operated exclusively for religious, charitable, scientific or 
educational purposes, the entity may be further classified as community-based, religious affiliated or 
university-sponsored.
Governmental: often called public health care entities, the entity is owned and operated by federal, state, 
city or county governments or other political subdivisions.
Investor- (or Operator-) Owned: a health care entity that operates as a stock corporation, partnership or 
sole proprietorship.
.03 Health care entities include, but are not limited to, the following:
• Clinics, medical group practices, individual practitioners and practice associations, and other ambulatory 
care organizations.
• Continuing care retirement communities (CCRCs).
• Health maintenance organizations and similar prepaid health care plans.
• Home health agencies.
• Hospitals.
• Nursing homes that provide skilled, intermediate, and less intensive levels of health care.
• Parent, holding and other organizations that primarily plan, organize and oversee health care services.
Legislation and Regulation
.04 Significant aspects of health care entity operations are affected by government legislation and regulation 
with many states adopting laws governing the granting of licenses, as well as scope of services to be rendered. In 
addition, many independent organizations and governmental agencies, including Medicare and Medicaid, evalu­
ate programs and services of health care entities to determine compliance with set standards.
Basic Financial Statements
.05 The basic financial statements of not-for-profit and governmental health care entities generally consist of a 
balance sheet, statement of revenues and expenses of general funds, statement of changes in fund balances, and a 
statement of cash flows of general funds (and restricted funds of governmental entities). The basic financial 
statements of investor-owned health care entities are similar to those of other investor-owned entities. Aggregated 
(combined fund) and disaggregated (layered fund) balance sheets are acceptable alternatives to reporting financial 
position of nonprofit health care entities and governmental hospitals.
3
Structure of the Checklist
.06 In July 1990, the AICPA published the audit and accounting guide entitled Audits of Providers of Health 
Care Services (the Guide). The recommendations contained in the Guide and this checklist apply to the separate 
financial statements of health care entities that are either (a) investor-owned, (b) not-for-profit or (c) state or local 
government-owned users of enterprise fund accounting and reporting. Financial statements of a state or local 
governmental health care entity are subject to statements and interpretations of the Governmental Accounting 
Standards Board (GASB) as well as to AICPA and Financial Accounting Standards Board (FASB) pronouncements, 
as specified by GASB statements and interpretations. This checklist presents fund accounting guidance first. Any 
modifications needed to reflect nonfund accounting are presented in brackets immediately after the related fund 
accounting guidance.
.07 Not-for-profit health care providers that receive federal financial assistance may be required to have an 
audit conducted in accordance with Office of Management and Budget (OMB) Circular A-133, Audits of 
Organizations of Higher Education and Other Nonprofit Organizations. Section 21,500 includes a checklist for 
auditor's reports for audits performed under OMB Circular A-133.
4
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Checklists—General
.01 Many auditors and accountants find it helpful to use checklists as practice aids in the preparation of 
financial statements and reports. Some firms have developed their own checklists for internal use and may also 
have specialized checklists to meet the needs of their practices, such as checklists for clients in particular industries 
or clients that report to the SEC. Some state CPA societies have developed checklists as practice aids that may be 
available to other practitioners, as well as to their own members. Some commercial publishers also include 
checklists in certain of their publications. However, authoritative literature does not require the use of such 
checklists, nor does it prescribe their format or content, which may vary.
.02 Checklists typically consist of a number of brief questions or statements that are accompanied by 
references to Statements on Auditing Standards, Statements on Standards for Accounting and Review Services, 
Statements of Financial Accounting Standards, Accounting Principles Board Opinions, and Accounting Research 
Bulletins. Some checklists also include references to FASB Interpretations, Statements of Position, and the AICPA 
Audit and Accounting Guides. The extent of detail included in checklists varies with the judgment of the preparers 
on how extensively to refer to and highlight authoritative literature without developing a checklist that is too long 
and unwieldy. Accordingly, checklists may serve as convenient memory aids but cannot be used as a substitute for 
direct reference to the authoritative literature.
.03 Checklists usually provide for checking off or initialling each question or point to show that it has been 
considered. The format used herein is a typical one; it provides for “yes," "no," and "not applicable" answers and 
presumes that remarks would be prepared on separate cross-referenced memorandums. Some preparers, however, 
prefer to include space for remarks in the body of the checklist, while others prefer alternative checklist formats. 
For example, a checklist format may provide for the following set of answers: "not applicable," "not material," "in 
statements," and "in notes" (with provisions for indicating a cross-reference to the specific statement caption or 
note). Another format may provide for only two answers, "disclosed" and "not applicable." Firms and practition­
ers who develop their own checklists should adopt formats that suit their needs and preferences.
.04 Checklists are generally accompanied by caveats that include all of the following points:
• Use of the checklists requires the exercise of individual professional judgment and may likely require 
some modification based on the circumstances of individual engagements.
• The checklists are not all-inclusive and are not intended to present minimum requirements.
• Users need to modify the checklists for any pronouncements issued subsequent to those mentioned in 
the checklist.
.05 If widespread circulation is expected, the preparers also generally stress the nonauthoritative or unofficial 
status of the checklists and disclaim responsibility for the way they may be used.
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Financial Statements and Notes Checklist
.01 This checklist has been developed by the staff of the Technical Information Division of the AICPA as a 
nonauthoritative practice aid.
.02 Explanation of References:
AAG = AICPA Audit and Accounting Guide, Audits of Providers of Health Care Services (with
conforming changes as of May 1, 1993)
AC = Reference to section number in FASB Accounting Standards—Current Text
APB = AICPA Accounting Principles Board Opinion
ARB = AICPA Accounting Research Bulletin
AU = Reference to section number in AICPA Professional Standards (vol. 1)
FASBI = FASB Interpretation
FASCON = FASB Statement of Financial Accounting Concepts 
SAS = AICPA Statement on Auditing Standards
SFAS = FASB Statement of Financial Accounting Standards
SOP = AICPA Statement of Position
TB = FASB Technical Bulletin
.03 Checklist Questionnaire
Yes No N/A
I. Accounting Principles of Display and Disclosure
A. Fund Accounting
1. General funds
a. For classified balance sheets, are assets and liabilities classified as current and 
noncurrent, with totals presented for current assets and current liabilities? 
[AAG, par. 3.04; ARB 43, Ch. 3A (AC B05.103—.109); SFAS 6, par. 15 (AC 
B05.118); TB 79-3 (AC B05.501—.503)]
b. Are agency funds (assets owned by others under agency relationships (such 
as patients or physicians) and their related liabilities) reported in the general 
funds?
c. Are transactions involving receipt and disbursement of agency funds 
excluded from the results of operations?
[AAG, par. 3.06]
d. Is property and equipment used for general operations (and related liabilities) 
reported in the general funds?
e. Is property and equipment not used for general operations (such as property 
acquired for future expansion or investment purposes) presented as a separate 
item in the general funds?
[AAG, pars. 3.07 and 8.06]
2. Donor-restricted funds
7
Yes
a. Is donor-restricted property and equipment (such as real estate investments of 
endowment funds) reported in the appropriate donor-restricted fund?
[AAG, pars. 3.07 and 8.07]
b. Are resources restricted by donors for additions to property and equipment 
reported in restricted plant replacement and expansion funds?
c. Are plant replacement and expansion funds reported in the statement of 
changes in fund balances when expenditures are incurred for the purpose 
intended by the donor?
[AAG, par. 3.10]
d. Do "term endowment funds" include resources whose principal may be 
expended after the donor-imposed time or after other restrictions are 
satisfied?
e. Is all pertinent information about term endowment funds (such as term and 
purposes) disclosed in the notes?
f. Are term endowment funds available for unrestricted purposes reported in 
the statement of revenues and expenses?
g. Are term endowment funds that became available, but are further restricted 
under the term endowment provisions, shown as a reclassification to the 
appropriate donor-restricted fund in the statement of changes in fund 
balances?
[AAG, par. 3.11]
h. Do endowment funds include resources whose principal may not be 
expended?
[AAG, par. 3.13]
8. Donated Funds Held in Trust
1. If donated resources are held in a trust (by an independent trustee), of which the 
provider is not the remainderman:
a. Are they excluded from the balance sheet?
b. Is their existence disclosed?
[AAG, par. 3.14]
2. Is disclosure considered of the right to future income and the principal held in 
trust?
3. If the provider received a distribution, is it reported in accordance with the terms 
of the trust or agreement with the trustee?
[AAG, par. 3.15]
4. If the provider is the remainderman, are the donated funds reported as assets
(depending on the terms of the trust document)?
[AAG, par. 3.16]
C. Financial Statements
1. For not-for-profit and governmental providers, do the basic financial statements 
include:
a. A balance sheet?
b. A statement of revenues and expenses of general funds?
c. A statement of changes in fund balances?
d. A statement of cash flows of general funds (and restricted funds of 
governmental entities)?
2. For investor-owned providers, are the basic financial statements similar to those 
of other investor-owned providers?
[AAG, par. 3.24]
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No N/A
Yes No N/A
II. Cash and Cash Equivalents
A. General
1. Is restricted cash appropriately segregated from cash available for current
operations? --------
[ARB 43, Ch. 3A, par. 6 (AC B05.107)]
2. Are restrictions on cash (such as for plant acquisition, debt reduction or working
capital maintenance) appropriately disclosed? --------
[SFAS 5, pars. 18—19 (AC C59.120)]
B. Personal Fund Accounts
1. Are personal funds of patients, residents and others under an agency
arrangement reported as assets and corresponding liabilities in the balance sheet? --------
2. Is the amount of personal funds reported as assets disclosed parenthetically on
the balance sheet or in the notes? --------
[AAG, par. 5.06]
C. Cash Equivalents
1. Is the policy for determining cash equivalents disclosed? --------
[SFAS 95, par. 10 (AC C25.108)]
III. Investments (See Exhibit A)
A. General
1. Are investments of general funds reported as current or noncurrent assets in
conformity with GAAP? --------
[AAG, par. 6.01]
2. Are the appropriate disclosures made for investments in common stock
accounted for by the equity method? --------
[APB 18, par. 20 (AC I82.110)]
3. Are other securities (such as real estate) reported at amortized cost, or at lower of
cost or market if an impairment in value is deemed to be other than temporary? --------
[AAG, par. 6.02c]
B. Debt and Equity Securities (See Exhibit A)1
1 SFAS 115 is not applicable to not-for-profit health care providers.
1. For debt and marketable equity securities classified as available-for-sale or held- 
to-maturity, are the following disclosures made, by major-security type, for each 
balance sheet presented:
a. Aggregate fair value? --------
b. Gross unrealized holding gains or losses? --------
c. Amortized cost basis? --------
d. Disclosure of major-security types, including:
(1) Equity securities? --------
(2) Debt securities issued by the U.S. Treasury and other U.S. government
corporations and agencies? --------
(3) Debt securities issued by states of the U.S. and political subdivisions of
the states? --------
(4) Debt securities issued by foreign governments? --------
(5) Corporate-backed securities? --------
(6) Mortgage-backed securities? --------
(7) Other debt securities? --------
(8) Other security types, as deemed appropriate? --------
[SFAS 115, par. 19 (AC I80.118)]  
9
Yes
2. For investments in debt securities classified as available-for-sale or held-to- 
maturity is:
a. Disclosure made about their contractual maturities, as of the date of the latest
balance-sheet date presented (maturity information may be combined in 
appropriate groupings)? _____
b. Disclosure made of the fair value and the amortized cost of debt securities in 
at least four maturity groupings:
(1) Within one year? _____
(2) After one year through five years? _____
(3) After five years through ten years? _____
(4) After ten years? _____
[SFAS 115, par. 20 (AC I80.119)]
3. Is consideration given to separate disclosure for securities not due at a single date
and the basis for allocation if such securities are allocated? _____
[SFAS 115, par. 20 (AC I80.119)]
4. Are realized gains or losses on the sale of investments of endowment funds
added to or deducted from the funds' principal (unless such amounts are legally 
available for other use or chargeable to other funds)? _____
[AAG, par. 6.13]
5. Are income and net realized gains or losses on investments of restricted funds 
(other than endowment funds) added to or deducted from the respective fund 
balance (unless such amounts are legally available for other use or chargeable to
other funds)? _____
a. If such amounts are legally available for unrestricted purposes, are they
reported in the statement of revenues and expenses? _____
b. Are gains or losses on investment trading between general and restricted 
funds and between various categories of restricted funds (such as between 
endowment and plant expansion funds) separately disclosed in the financial
statements? _____
[AAG, par. 6.14]
IV. Receivables
1. Are charity care revenue and receivables excluded from the financial statements? _____
[AAG, par. 7.02]
2. Are differences between the estimates originally reported and final settlements:
a. Included in the statement of revenues and expenses (statement of operations)
in the period the settlements are made? _____
b. Reported in the current period unless they meet the criteria for prior-period
adjustments? _____
[AAG, par. 7.09; SFAS 16 (AC A35)]
3. Are advances from third-party payors reported as a liability (unless the right of
setoff against a related receivable applies)? _____
[AAG, par. 7.11]
4. Are deposits received from individuals reported as a liability (to the extent that a
right of setoff does not exist)? _____
[AAG, par. 7.12]
5. Are receivables (less an allowance for uncollectibles, discounts, and contractual
adjustments) reported as current assets in the general funds? _____
a. If the terms of payment are extended beyond one year from the balance-sheet
date, is that portion classified as noncurrent? _____
b. Is consideration given to segregating amounts due from third-party payors for
retroactive adjustments of items (such as final settlements or appeals)? _____
[AAG, par. 7.16]
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Yes No N/A
6. If financial statements present assets and liabilities by fund groups:
a. Are interfund receivables or payables reported separately by fund?
b. In a classified balance sheet, are they reported as current or noncurrent in 
general funds?
7. If financial statements do not present assets and liabilities by fund groups, are 
interfund receivables and payables eliminated?
8. Are circumstances and terms of formal interfund borrowing agreements 
disclosed?
[AAG, par. 7.17]
9. Are pledges reported in the period in which they were made?
a. Are pledges reported net of an allowance for uncollectible amounts?
b. Are unrestricted pledges reported in the statement of revenues and expenses 
(statement of operation)?
c. If a portion of a pledge is to be applied during some future period, is that part 
reported in the general fund in the period in which it is received as deferred 
revenue or, if restricted, as an addition to donor-restricted funds?
d. If pledges are restricted in any other way, are they reported as additions to 
donor-restricted funds?
[AAG, par. 7.18]
10. Are all receivables reported net of any related allowance for uncollectible 
amounts, with appropriate disclosure?
[AAG, par. 7.19; APB 12, par. 3 (AC V18.102)]
11. Are accounts and notes receivable from officers, employees, and affiliated 
organizations shown separately with appropriate disclosures?
[ARB 43, Ch. 1A, par. 5 (AC R36.105)]
V. Property and Equipment, Supplies, and Other Assets
1. Is property and equipment of donor-restricted funds (such as property received as 
a donation to endowment funds) reported in the appropriate donor-restricted 
fund?
[AAG, par. 8.07]
2. Are donor or legal restrictions on the proceeds from the disposition of property 
and equipment disclosed?
[AAG, par. 8.06]
3. For depreciable assets, do the financial statements or notes disclose:
a. Depreciation expense for each period?
b. Balances of major classes of depreciable assets by nature or function?
c. Accumulated depreciation, either by major classes of assets or in total?
d. The method or methods used in computing depreciation with respect to major 
classes of depreciable assets?
[APB 12, par. 5 (AC D40.105)]
4. Do disclosures include the method and period of amortization of intangible 
assets?
[APB 22, par. 13 (AC A10.106)]
5. In a classified balance sheet:
a. Are deferred tax assets classified as current or noncurrent based on the 
classification of the related asset or liability for financial reporting?
[SFAS 109, par. 41 (AC I27.140)]
b. Are deferred tax assets not related to an asset or liability for financial 
reporting (including those related to carryforwards) classified according to the 
expected reversal date of the temporary difference?
[SFAS 109, pars. 41 and 288p (AC I27.140)]
11
Yes
c. Is the valuation allowance for a particular tax jurisdiction allocated between 
current and noncurrent deferred tax assets for that tax jurisdiction on a pro
rata basis?
[SFAS 109, par. 41 (AC I27.140)]
d. Are the following items offset and presented as a single amount for a 
particular taxpaying component and within a particular taxpaying 
jurisdiction:
(1) All current deferred tax liabilities and assets?
(2) All noncurrent deferred tax liabilities and assets?
[SFAS 109, par. 42 (AC I27.141)]
6. Are the totals of (a) all deferred tax assets and (b) the related valuation allowance 
recognized in the balance sheet disclosed?
[SFAS 109, par. 43 (AC 127.142)]
7. Is an asset (prepaid pension cost) recognized if net periodic pension cost is less 
than amounts the employer has contributed to the plan?
[SFAS 87, par. 35 (P16.129)]
8. If an additional minimum pension liability is recognized, is an equal amount 
recognized as an intangible asset, provided that the asset recognized does not 
exceed the amount of unrecognized prior-service cost?
[SFAS 87, pars. 36—37 (AC P16.130—.131)]
VI. Current Liabilities, Notes Payable, and Other Debt
A. Current Liabilities
1. Do current liabilities include:
a. Obligations for items that enter the operating cycle?
b. Collections received in advance of the performance of services?
c. Debts that arise from operations directly related to the operating cycle?
d. Other liabilities whose regular and ordinary liquidation is likely to occur 
within a relatively short time period?
e. Obligations that, by their terms, are due on demand or will be due within one 
year (or operating cycle, if longer) from the balance-sheet date, even though 
liquidation may not be expected within that period?
[ARB 43, Ch. 3A, pars. 7—8 (AC B05.108—.109); SFAS 78, par. 5 (AC 
B05.109A)]
2. Do current liabilities exclude short-term obligations that the provider intends to 
refinance on a long-term basis, provided the provider has demonstrated the 
ability to consummate the long-term financing?
[SFAS 6, pars. 8—14 (AC B05.112—.116)]
B. Notes Payable and Other Debt
1. Is there adequate disclosure of interest rates, maturities, and other terms and 
conditions provided in loan agreements and bond indentures (such as assets 
pledged as collateral, and covenants to reduce debt, and maintain working 
capital)?
[FASCON 5, par. 11; SFAS 5, par. 18 (AC C59.120)]
2. Are the combined aggregate amounts of maturities and sinking fund 
requirements for all long-term borrowings disclosed for each of the five years 
following the date of the latest balance sheet presented?
[SFAS 47, par. 10b (AC C32.105b)]
3. If note is noninterest bearing or has an inappropriate stated interest rate:
a. Is the discount or premium presented as a deduction from or addition to the 
face amount of the note?
12
No N/A
Yes
b. Does the disclosure include the effective interest rate and face amount of the
note? --------
c. Is amortization of the discount or premium reported as interest expense? --------
d. Are issue costs reported in the balance sheet as deferred charges? --------
[APB 21, par. 16 (AC I69.109)]
4. Are debt conversion features (such as rates and pertinent dates) disclosed? --------
[FASCON 5, par. 11; APB 14 (AC D10)]
5. If a short-term obligation is to be excluded from current liabilities in a classified 
balance sheet, do disclosures include:
a. General description of the financing agreement? --------
b. Terms of any new obligation incurred or expected to be incurred, or equity
securities issued or expected to be issued as a result of the refinancing? --------
[SFAS 6, par. 15 (AC B05.118)
6. For troubled debt restructuring occurring during the current period, do 
disclosures include:
a. Description of the principal changes in terms and/or the major features of
settlement? --------
b. Aggregate gain on restructuring of payables and the related income tax effect? --------
c. Aggregate net gain or loss on transfers of assets recognized during the period? --------
d. Per-share amount, if applicable, of the aggregate gain on restructuring of
payables, net of related income tax effect? --------
[SFAS 15, par. 25 (AC D22.121)]
7. For periods after a troubled debt restructuring, do disclosures include:
a. Extent to which amounts contingently payable are included in the carrying
amount of restructured payables? --------
b. Total amounts contingently payable, if applicable, and conditions under
which those amounts would become payable or forgiven? --------
[SFAS 15, par. 26 (AC D22.122)]
8. If there is an early extinguishment of debt, is the difference between reacquisition
price and carrying amount identified as a separate or extraordinary item? --------
[SFAS 4, par. 8; SFAS 64, par. 4 (AC D14.105)]
9. If debt is considered to be extinguished early, do disclosures include:
a. A general description of the transaction? --------
b. The amount of debt that is considered extinguished as long as the debt
remains outstanding? --------
[SFAS 76, par. 6 (AC D14.108)]
10. Are long-term obligations that are or will be callable by the creditor, either 
because the debtor's violation of the debt agreement at the balance-sheet date 
makes the obligation callable, or because the violation (if not cured within a 
specified grace period) will make the obligation callable, classified as current 
unless one of the following conditions is met:
a. The creditor waives or subsequently loses the right to demand repayment for 
more than one year (or operating cycle, if longer) from the balance-sheet
date? --------
b. The obligation contains a grace period within which the debtor may cure the 
violation and it is probable that the violation will be cured within that period,
thus preventing the violation from becoming callable? --------
[SFAS 78, par. 5 (AC B05.109A)]
13
No N/A
Yes
11. Does the not-for-profit provider report tax-exempt obligations that were issued
for its benefit as liabilities in the general funds? _____
[AAG, par. 9.04]
12. Is consideration given to the effects, if any, of current and prior tax examinations
on the financial statements and disclosures related to the existence of contingent 
liabilities for unrelated business income tax, additional payroll tax liabilities, or 
penalties and interest on delinquent taxes? _____
13. Is disclosure considered for any changes in the provider's activities that could
affect its tax-exempt status? _____
14. Are disclosures appropriate regarding the provider's tax-exempt status and any
other significant tax matters? _____
15. Is appropriate disclosure made if unrelated business income tax has not been 
accrued on income from:
a. Debt-financed investments that are not functionally related to the exempt
purpose? _____
b. Certain related entities not engaged in an exempt activity? _____
c. Pharmacy operations in a medical building for the convenience of physicians'
private patients? _____
d. A gift shop, cafeteria or food shop that the provider encourages the general
public (except patients, visitors and employees) to use? _____
e. A parking lot available to the general public (except patients, visitors, and
employees)? _____
16. Is consideration given to disclosing the effects of the Tax Reform Act of 1986 that
added arbitrage restrictions regarding tax-exempt bonds? _____
[AAG, pars. 9.19—.33; SFAS 5, pars. 9—10 (AC C59.108—.111)]
VII. Commitments and Contingencies
A. Uninsured Medical Malpractice Claims
1. If a minimum amount of a probable loss (usually associated with litigating or
setting malpractice claims) is accrued, is there disclosure as to a reasonable 
possibility of an additional potential loss in excess of the amount accrued? _____
2. If a range of loss cannot be reasonably estimated, is a contingency disclosed? _____
[AAG, par. 10.04; SFAS 5(AC C59)]
3. Is the program of medical malpractice coverage and basis for loss accruals
disclosed? _____
[AAG, par. 10.11; SFAS 5(AC C59)]
4. If the provider discounts accrued malpractice claims, are the following disclosed:
a. The carrying amount of the claims? _____
b. The interest rates or other rates used to discount the claims? _____
[AAG, par. 10.12]
B. Retrospectively Rated Premiums
1. If the provider cannot estimate losses from asserted or unasserted malpractice
claims, is the existing contingency disclosed? _____
[AAG, par. 10.14; SFAS 5(AC C59)]
2. Does the provider disclose that it is insured under a retrospectively rated policy? _____
3. Does the provider disclose that premiums are accrued based on the ultimate cost
of the experience to date of a group of entities? _____
4. If losses cannot be estimated, is the existing contingency disclosed? _____
[AAG, par. 10.15; SFAS 5(AC C59)]
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No N/A
Yes
C. Medical Malpractice Claims Insured with Captive Insurance Companies
(Controlled by a parent entity for the main purpose of providing insurance for 
the parent)
1. Does the provider disclose that it is insured under a retrospectively rated policy of 
a multiprovider captive?
2. Does the provider disclose that premiums are accrued based on the captive's 
experience to date?
[AAG, par. 10.18]
3. Is the provider's ownership percentage in the captive disclosed?
4. Is the method of accounting for its investment in and the operations of the 
captive disclosed?
[AAG, par. 10.19]
5. If the provider cannot make the necessary estimates of losses from asserted or 
unasserted claims, does it disclose the existing contingency?
[AAG, par. 10.19; SFAS 5 (AC C59)]
D. Trust Funds
1. If trust funds (revocable or irrevocable) are included in the provider's financial 
statements:
a. Is a portion of the funds (the amount of assets expected to be liquidated to 
pay malpractice claims classified as current liabilities) classified as a current 
asset in a classified balance sheet?
b. Is the balance of the funds, if any, classified as a noncurrent asset in a 
classified balance sheet?
c. Are trust fund revenue and administrative expenses included in the statement 
of revenues and expenses (statement of operations)?
[AAG, par. 10.20]
d. Are estimated losses from asserted and unasserted claims reported?
[AAG, par. 10.21]
e. Is the existence of trust funds and whether they are irrevocable disclosed? 
[AAG, par. 10.22]
E. Prepaid Health Care Services
1. Health Care Costs
a. Is the basis for accruing health care costs disclosed?
b. Are significant business and contractual arrangements with hospitals, 
physicians, and other associated entities disclosed?
[SOP 89-5 (AAG, Appendix B), par. 32]
2. Stop-Loss Insurance
a. Are receivables representing amounts recoverable from insurers reported as 
assets net of any valuation allowance?
b. Are the nature, amounts, and effects of significant stop-loss insurance 
contracts disclosed?
[SOP 89-5 (AAG, Appendix B), par. 49]
F. Other Disclosures
1. Are the nature and, if applicable, amount (or a statement that no loss estimate can 
be made) disclosed for loss contingencies (including guarantees)?
[SFAS 5, pars. 9—12 and FASBI 34, pars. 2—3 (AC C59.108—.114)]
2. Are gain contingencies adequately disclosed with care to avoid misleading 
implications as to the likelihood of realization?
[SFAS 5, par. 17 (AC C59.118)]
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No N/A
Yes
3. Are the nature, term, amount and other required information disclosed for long­
term unconditional purchase obligations? _____
[SFAS 47, pars. 7 and 10a (AC C32.102 and .105a)]
4. If an obligation for postemployment benefits (other than pensions) is not accrued 
in accordance with SFAS 5 (AC C59) or SFAS 43 (AC C44) only because the 
amount cannot reasonably be estimated and the financial statements are for a 
fiscal year beginning after December 15, 1993, is the fact of nonaccrual disclosed
in the financial statements? _____
[SFAS 112, par. 7 (AC P32.105)]
VIII. Net Assets (Equity or Fund Balances)
A. Financial Statement Presentation
1. Are the equity accounts of investor-owned providers presented in a similar
fashion as other investor-owned businesses? _____
2. Are the net assets of not-for-profit and governmental providers (that use the
disaggregated method) displayed as general and donor-restricted fund balances? _____
3. Are the net assets of not-for-profit and governmental providers (that use the 
aggregated method) displayed as unrestricted, temporarily restricted or
permanently restricted fund balances as appropriate? _____
[AAG, par. 11.01]
4. Is the nature of restrictions on donor-restricted resources disclosed? _____
[AAG, par. 11.02]
5. Shareholders' Equity (Corporations)
a. Do the financial statements include a description, in summary form, sufficient 
to explain the pertinent rights and privileges of the various securities 
outstanding, (e.g., dividend and liquidation preferences, participation rights, 
call prices and dates, conversion or exercise prices or rates and pertinent
dates, sinking fund requirements, unusual voting rights)? _____
[APB 15, par. 19 (AC E09.110)]
b. For preferred stock, do disclosures include:
(1) Aggregate or per share amounts at which shares may be called or are
subject to redemption? _____
[APB 10, par. 11 (AC 06.102)]
(2) Aggregate and per share amounts of arrearages in cumulative preferred
dividends? _____
[APB 15, par. 50, fn. 16 (AC 06.102)]
c. For stock option and stock purchase plans, do disclosures include:
(1) Number of shares under option? _____
(2) Option price? _____
(3) Number of shares as to which options are exercisable? _____
(4) For options exercised, the number of shares involved and option price? _____
[ARB 43, Ch. 13B, par. 15 (AC C47.123)]
d. Are any appropriations of retained earnings for loss contingencies clearly
identified and included in stockholders' equity? _____
[SFAS 5, par. 15 (AC R70.103)]
e. Are restrictions on payment of dividends disclosed? _____
[SFAS 5, pars. 18—19 (AC C59.120)]
f. Are receivables for stock issued or subscribed appropriately identified and 
presented as a deduction from capital or, if presented as an asset, stated 
separately, clearly labeled, and their status clearly described to distinguish
them from any other type of assets? _____
16
No N/A
Yes
g. Are the amounts of redemption requirements for all issues of capital stock 
that are redeemable at fixed or determinable prices on fixed or determinable 
dates disclosed for each of the five years following the date of the latest
balance sheet presented? _____
[SFAS 47, par. 10 (AC C32.105)]
6. Changes in Net Assets (Fund Balances)
a. When both financial position and results of operations (or revenue and 
expenses of general funds) are presented:
(1) Are changes in the separate component accounts of equity (or fund
balances) disclosed? _____
[APB 12, par. 10 (AC C08.102); AAG, par. 3.24]
(2) Are changes in the number of shares of capital stock disclosed for at least 
the latest year and any subsequent interim periods presented (for-profit
only)? _____
[APB 12, par. 10 (AC C08.102)]
b. Are prior-period adjustments and their resulting effects (both gross and net of
applicable income taxes) appropriately presented and disclosed? _____
[APB 9, par. 26 (AC A35.107)]
c. If an additional pension liability is required to be recognized and exceeds 
unrecognized prior service cost, is the excess (which would represent a net 
loss not yet recognized as net periodic pension cost) reported as a separate 
component (i.e., a reduction) of equity net of any tax benefits that result from
considering such losses as temporary differences? _____
[SFAS 87, par. 37 (AC P16.131)]
IX. Revenues, Expenses, Gains, and Losses
A. Conceptual Framework for Reporting and Classification
1. Are revenues and expenses (arising from ongoing activities associated with health
care services) classified as operating and displayed as gross amounts? _____
2. Is display of gains and losses (resulting from peripheral or incidental transactions 
and from other events (environmentally related and largely uncontrollable)) as
net amounts considered? _____
[AAG, pars. 12.01—.02]
3. Are gains and losses classified in relation to major ongoing or central operations 
such as:
a. Operating, if related? _____
b. Nonoperating, if peripheral, incidental or unrelated? _____
[AAG, par. 12.03]
4. For investments in common stock accounted for by the equity method, is the 
investor's share of earnings shown as a single amount except for investee 
extraordinary items and prior-period adjustments that are material to the
investor? _____
[APB 18, pars. 19c—d (AC I
5. Are total research and development costs charged to expenses disclosed for each
period to which a statement of revenues and expenses (operations) is presented? _____
[SFAS 2, pars. 12—13 (AC R50.108—.109); FASBI 4, par. 5 (AC B50.152); FASBI
6, par. 8 (AC R50.117); SFAS 68, par. 14 (AC R55.112); SFAS 86, par. 3 (AC 
Co2.102)]
6. Is the amount of interest cost incurred disclosed in the statements or notes 
thereto, and for an accounting period in which some interest cost is capitalized,
the total amount thereof that has been capitalized? _____
[SFAS 34, par. 21 (AC I67.118)]
7. If the provider accounts for its obligation under a research and development 
arrangement as a contract to perform research and development for others, is 
there disclosure of:
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Yes
a. The terms of significant agreements under the research and development
arrangement as of the date of each balance sheet presented? _____
b. The amount of compensation earned or costs incurred under such contracts 
for each period for which a statement of revenues and expenses (statement of
operations) is presented? _____
[SFAS 68, par. 14 (AC R55.112)]
B. Revenue
1. Is revenue classified based on the type of service (such as patient or resident)
rendered or contracted to be rendered? _____
[AAG, par. 12.04]
2. Are contributions, tax support, and other subsidies classified as:
a. Gains, when peripheral or incidental to health care activities? _____
b. Revenues, if deemed ongoing major or central activities to provide health care
services? _____
[AAG, par. 12.05]
3. Is other revenue (such as from sales and services, other than health care, to 
patients, residents, nonpatients or visitors):
a. Classified as operating? _____
b. Stated separately? _____
[AAG, pars. 12.06—.07]
4. Are gains and losses properly classified and reported? _____
[AAG, par. 12.08]
C. Financial Statement Presentation (See Exhibit A)
1. Is service revenue reported net of contractual charity care and other adjustments? _____
[AAG, par. 12.11]
2. Do disclosures include the methods of:
a. Revenue recognition? _____
b. Recording unrestricted and restricted donations and investment income of
both general and restricted funds? _____
3. With regard to contractual adjustments and third-party settlements, does the
provider identify and explain the estimated amounts payable or receivable? _____
[AAG, par. 12.13]
4. Are expenses incurred to solicit contributions separately disclosed? _____
[AAG, par. 12.16]
5. For each period for which an earnings statement is presented, are the following 
disclosures made:
a. The proceeds from sales of available-for-sale securities and gross realized
gains and losses on those sales? _____
b. The basis on which cost was determined in computing realized gain or loss
(i.e., specified identification, average cost, or other method used)? _____
c. The gross gains and losses included in earnings from transfers of securities
from the available-for-sale category to the trading category? _____
d. The change in net unrealized holding gain or loss on available-for-sale
securities that is included in the separate component of shareholders' equity 
during the period? _____
e. The change in net unrealized holding gain or loss on trading securities that is
included in earnings during the period? _____
[SFAS 115, par. 21 (AC I80.120)]
6. For any sales of or transfers from securities classified as held-to-maturity, are the 
following disclosed for each period for which an earnings statement is presented:
a. Amortized cost amount of the sold or transferred security? _____
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No N/A
Yes No N/A
b. Related realized or unrealized gain or loss?
c. The circumstances leading to the decision to sell or transfer the security?
[SFAS 115, par. 22 (AC I80.114—.122)]
7. Income Taxes
a. Are the types of significant temporary differences and carryforwards 
disclosed?
[SFAS 109, par. 43 (AC 127.142)]
b. Are the following significant components of income tax expense attributable 
to continuing operations for each year presented disclosed in the financial 
statements or notes thereto:
(1) Current tax expense or benefit?
(2) Deferred tax expense or benefit (exclusive of the effects of other 
components listed below)?
(3) Investment tax credits?
(4) Government grants (to the extent recognized as a reduction of income tax 
expense)?
(5) The benefits of operating loss carryforwards?
(6) Tax expense that results from allocating certain benefits, either directly to 
contributed capital or to reduce goodwill or other noncurrent intangible 
assets of an acquired entity?
(7) Adjustments of a deferred tax liability or asset for enacted changes in tax 
laws or rates or a change in the tax status of the provider?
(8) Adjustments of the beginning-of-the-year balance of a valuation 
allowance because of a change in circumstances that causes a change in 
judgment about the realizability of the related deferred tax asset in future 
years?
[SFAS 109, par. 45 (AC I27.144)]
c. Is the amount of income tax expense or benefit allocated to continuing 
operations and the amounts separately allocated to other items disclosed for 
each year for which those items are presented?
[SFAS 109, pars. 35—39 and 46 (AC I27.134—.138 and .145)]
d. Is the nature of significant reconciling items disclosed?
[SFAS 109, par. 47 (AC I27.146)]
e. Are the amounts and expiration dates of operating loss and tax credit 
carryforwards for tax purposes disclosed?
[SFAS 109, par. 48 (AC I27.147)]
f. If the provider is a member of a group that files a consolidated tax return, are 
the following items disclosed in its separately-issued financial statements:
(1) The aggregate amount of current and deferred tax expense for each period 
presented, and the amount of any tax-related balances due to or from 
affiliates as of the date of each balance sheet presented?
(2) The method by which the consolidated amount of current and deferred 
tax expense is allocated to members of the group and the nature and 
effect of any changes in that method (and in determining related balances 
to or from affiliates) for each period presented?
[SFAS 109, par. 49 (AC I27.148)]
8. Discontinued Operations
a. Are operations of a segment that are discontinued or are the subject of a 
formal plan for disposition:
(1) Reported separately from continuing operations and as a component 
(including applicable income taxes) of operations before extraordinary 
items?
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Yes
(2) Accompanied by disclosure in the notes of revenue applicable to the 
discontinued operations?
b. Is gain or loss from disposal of a discontinued segment reported separately
(including applicable income taxes) in conjunction with results of 
discontinued operations as a component of income before extraordinary 
items?
[APB 30, pars. 8, 13 and 15—18 (AC I13.101—.103, .105—.106 and .108— 
.109)]
c. For the period encompassing the measurement date, do notes to financial 
statement disclose:
(1) Identity of the segment discontinued?
(2) Expected disposal date, if known?
(3) Expected manner of disposal?
(4) Description of the remaining assets and liabilities of the discontinued 
segment at the balance-sheet date?
(5) Results of operations and any proceeds from disposal of the discontinued 
segment during the period from the measurement date to the balance- 
sheet date?
[APB 30, par. 18 (AC I13.108—.109)]
d. For periods after the measurement date and including the disposal, do notes 
to financial statements disclose the information required for the period 
encompassing the measurement date and the actual date and results of 
disposal compared with the prior estimates?
[APB 30, par. 18 (AC I13.108—.109)]
9. Extraordinary Items
a. Are extraordinary items segregated and shown (including applicable income 
taxes) after income before extraordinary items and before net income?
[APB 30, par. 10—12 (AC I17.102—.103)]
b. Are descriptive captions and amounts (including applicable income taxes) 
presented for individual extraordinary events or transactions, preferably on 
the face of the income statement, if practicable?
c. Do disclosures include descriptions of extraordinary events or transactions 
and the principal items entering into determination of extraordinary gains or 
losses?
[APB 30, par. 11 (AC I17.102)]
d. For gains or losses from extinguishment of debt classified as extraordinary 
items, do disclosures include:
(1) Description of the extinguishment transactions, including the sources of 
any funds used to extinguish the debt if it is practicable to identify the 
sources?
(2) Income tax effect in the period of extinguishment?
(3) Per share amount (if applicable) of the aggregate gain or loss net of 
related income tax effect?
[SFAS 4, pars. 8—10 (AC I17.104 and D14.105—.107)]
e. For an adjustment of an extraordinary item reported in a prior period (except 
for correction of an error):
(1) Is the adjustment classified separately as an extraordinary item in the 
current period?
(2) Are the nature, origin, and amount of the item disclosed?
[SFAS 16, par. 16(c) (AC I17.119)]
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No N/A
Yes No N/A
10. Are material events or transactions that are either unusual in nature or of 
infrequent occurrence, but not both (and therefore not meeting criteria for 
extraordinary items):
a. Reported as a separate component of income from continuing operations? --------
b. Accompanied by disclosure of the nature and financial effects of each event? --------
[APB 30, par. 26 (AC I22.101)]
11. Do disclosures for advertising costs include:
a. The accounting policy selected from the two alternatives in the beginning of 
paragraph 26 of SOP 93-7 for reporting advertising, indicating whether such
costs are expensed as incurred or the first time the advertising takes place? _____
b. A description of the direct-response advertising reported as assets (if any), the
accounting policy for it, and the amortization period? _____
c. The total amount charged to advertising expense for each income statement
presented, with separate disclosure of amounts, if any, representing a write­
down to net realizable value? _____
d. The total amount of advertising reported as assets in each balance sheet
presented? _____
[SOP 93-7, par. 49]
X. Statement of Cash Flows
A. Is a statement of cash flows presented as a basic financial statement for each 
period for which a statement of revenues and expenses (statement of operations) 
is presented for:
1. General funds of a nonprofit or governmental entity? _____
2. Restricted funds of a governmental entity? _____
3. Any investor-owned entity? _____
[SFAS 95, par. 3 (AC C25.101); AAG, pars. 3.24—.25]
B. Does the statement of cash flows explain the effect of cash flows by showing the
change in cash and cash equivalents? _____
[SFAS 95, par. 7 (AC C25.105)]
C. Is the policy for defining cash equivalents disclosed? _____
[SFAS 95, par. 10 (AC C25.108)]
D. If the direct method is used, is a reconciliation of the excess of revenues and 
expenses (income) to net cash flow from operating activities provided in a
separate schedule? _____
[SFAS 95, par. 30 (AC C25.128)]
E. If the indirect method is used:
1. Is the same amount for net cash flow from operating activities reported indirectly 
by adjusting the excess of revenues and expenses (income) to reconcile it to net
cash flow from operating activities? _____
[SFAS 95, par. 28 (AC C25.126)]
2. Is the reconciliation of the excess of revenues and expenses (income) to net cash 
flow from operating activities reported, either within the statement of cash flows 
or provided in a separate schedule, with the statement of cash flows reporting
only the net cash flow from operating activities? _____
[SFAS 95, par. 30 (AC C25.128)]
F. Are cash receipts and cash payments for the following transactions classified as 
cash flows from operating activities:
1. Interest received on loans? _____
2. Insurance proceeds except those directly related to investing or financing
activities? _____
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Yes
3. Interest paid to creditors?
4. Payments to suppliers and employees?
5. Payments to governments for taxes, duties, fines, and other fees or penalties?
6. Payments to settle lawsuits?
7. Contributions to charities?
[SFAS 95, pars. 22—23 (AC C25.120—.121)]
G. Are cash receipts and cash payments for the following transactions classified as 
cash flows from investing activities:
1. Receipts from collections or sales of loans?
2. Receipts from sales of property?
3. Loans to others?
4. Payments to acquire property?
[SFAS 95, pars. 16—17 (AC C25.114—.115)]
H. Are cash receipts and cash payments for the following transactions classified as 
cash flows from financing activities:
1. Proceeds from issuing debt?
2. Repayments for amounts borrowed?
[SFAS 95, pars. 19—20 (AC C25.117—.118)]
I. Except for certain items whose turnover is quick, amounts are large and maturities 
are short, are cash receipts and cash payments from investing and financing 
activities shown separately on the statement of cash flows?
[SFAS 95, pars. 12—13 and 31 (AC C25.110—.111 and .129)]
J. Are noncash investing and financing activities (such as converting debt to equity) 
summarized in a separate schedule or the notes?
[SFAS 95, par. 32 (AC C25.134)]
XI. Related Organizations and Economic Dependency
A. Consolidation and Combination (See Exhibit A)
1. If the provider and another entity are related and they meet the criteria for 
consolidation or combination ("consolidation"), are consolidated or combined 
("consolidate") financial statements presented?
[AAG, par. 13.2; ARB 51 (AC C51); SFAS 94 (AC C51)]
2. If consolidated statements are presented:
a. Is the consolidation policy disclosed?
[ARB 51, par. 5 (AC C51.108); APB 22, par. 13 (AC A10.106)]
b. When the financial reporting periods of consolidated entities differ, is 
recognition given, by disclosure or otherwise, to the effect of intervening 
events that materially affect financial position or results of operations?
[ARB 51, par. 4 (AC C51.107); FASBI 13, pars. 6—8 (AC I89.120—.122)]
3. Do disclosures about formerly unconsolidated subsidiaries that are now 
consolidated include summarized information about the assets, liabilities, and 
results of operations (or separate statements) in the consolidated financial 
statements or notes?
[AAG, par. 13.02; SFAS 94, par. 14 (AC C51.120A)]
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No N/A
Yes No N/A
B. Related Parties and Economic Dependency
1. If the entity does not meet the criteria for consolidation or combination, but 
controls and is the sole beneficiary of a related organization's activities, is 
summarized financial data of the related organization disclosed?
[AAG, pars. 13.03—.04]
2. For any related party that is not consolidated or combined, does the entity 
disclose (even if there are no transactions between them):
a. The nature of the relationship between the entity and the related party?
b. If there are material transactions between the entity and the related party:
(1) A description of the transactions, including transactions to which nominal 
or no amounts were ascribed?
(2) The amount of such transactions? --------
(3) Amounts due from or to the related party and, if not apparent, the terms
and manner of settlement? --------
AAG, par. 13.05; SFAS 13, par. 29 (AC L10.125); SFAS 57, pars. 2—4 
(AC R36.102—.104)]
XII. Continuing Care Retirement Communities (CCRCs)
A. Refundable Advance Fees
1. Is the estimated amount of advance fees expected to be refunded to current
residents reported as a liability? --------
2. Is the remaining amount of advance fees reported in the balance sheet as deferred
revenue? --------
3. Are the following disclosed:
a. The gross amount of contractual refund obligations under existing contracts? --------
b. The CCRC's refund policy? --------
4. Are amounts refunded disclosed in the statement of cash flows as a financing
transaction? --------
[SOP 90-8 (AAG, Appendix C), par. 22]
5. Is the method of accounting, including the amortization method, for deferred
revenue disclosed? --------
[AAG, par. 9.34; SOP 90-8 (AAG, Appendix C), pars. 23, 31 and 43]
B. Fees Refundable to Residents Only From Reoccupancy Proceeds of a Contract 
Holder's Unit
1. Are the following reported as deferred revenue:
a. The portion of fees to be paid to current residents or their designees, only to 
the extent of a contract holder's unit reoccupancy proceeds, if law and 
management policy and practice support the withholding of refunds under 
this condition?
b. Similar amounts received from new residents in excess of the amount to be
paid to previous residents or their designees?SOP 90-8 (AAG, Appendix C), par. 31]
C. Nonrefundable Advance Fees
1. Are nonrefundable advance fees reported as deferred revenue?
2. Is unamortized deferred revenue reported as revenue upon a resident's death or 
contract termination?
[SOP 90-8 (AAG, Appendix C), pars. 23 and 43]
D. Obligation to Provide Future Services and Use of Facilities to Current 
Residents
1. If the obligation to provide future services and use of facilities to current residents 
under continuing-care contracts results in a liability, are the following disclosed:
a. The carrying amount of the liability?
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Yes
b. The interest rate used to discount that liability?
[SOP 90-8 (AAG, Appendix C), par. 55]
E. Costs of Acquiring Initial Continuing-Care Contracts
1. Are costs of acquiring initial continuing-care contracts capitalized if they are 
expected to be recovered from future contract revenues?
2. Are continuing-care contract acquisition costs expensed if incurred after (a) the 
CCRC is substantially occupied or (b) one year following completion?
[SOP 90-8 (AAG, Appendix C), par. 63]
XIII. Financial Statements and Notes—General
A. Titles and References
1. Are the financial statements suitably titled?
[SAS 62, par. 7 (AU 623.07)]
2. Does each statement include a general reference that the notes are an integral 
part of the financial statement presentation?
3. Do the note captions and the referencing from the applicable statement 
classifications seem appropriate?
[FASCON, par. 18]
B. Disclosure of Accounting Policies
1. Is a description of all pertinent accounting policies of the provider presented as an 
integral part of the financial statements?
[APB 22, pars. 8—9 (AC A10.102—.103)]
2. Does disclosure of significant accounting policies encompass important 
judgments as to the appropriateness of principles concerning recognition of 
revenue and allocation of asset costs to current and future periods?
[APB 22, par. 12 (AC A10.105)]
3. Does disclosure of significant accounting policies include appropriate reference to 
details presented elsewhere (in the statements and notes thereto) so duplication 
of details is avoided?
[APB 22, par. 14 (AC A10.107)]
C. Accounting Changes
1. For an accounting change, does disclosure in the period of the change include:
a. Nature of the change?
b. Justification for the change, including a clear explanation of why the newly 
adopted principle is preferable?
c. Effect on income?
[APB 20, par. 17 (AC A06.113)]
2. For changes in accounting principle (excluding specific exceptions related to an 
initial public offering, change in the reporting entity, or adoption of certain 
authoritative pronouncements):
a. If comparative financial statements are included, are they presented as 
previously reported?
b. Is the cumulative effect of the change (direct effects and income tax effects 
only) on beginning retained earnings for the period of the change shown in 
the statement of revenues and expenses (statement of operations) of that 
period, after any extraordinary items and before net revenue and gains in 
excess of expenses and losses (net income)?
c. Is the effect of adopting the new accounting principle on revenue and gains in 
excess of expenses and losses (income) before extraordinary items and net 
revenue and gains in excess of expenses and losses (net income) (and 
applicable per share data) disclosed for the period of the change?
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No N/A
Yes No N/A
d. Are pro forma revenues and gains in excess of expenses and loss (income)
before extraordinary items and net revenue and gains in excess of expenses 
and losses (net income) shown on the face of the statement of revenue and 
expenses (statement of operations) for all periods presented as if the newly 
adopted accounting principle had been applied during all periods affected? --------
e. If pro forma amounts or cumulative effects cannot be determined, are the
reasons disclosed? --------
[APB 20, pars. 12, 17—22, 24—26, 29 and 34 (AC A06.113—.118, .120—.122
and .125, and A35.112 and .114); FASBI 20, par. 5 (A06.127)]
3. Is the correction of an error shown as a prior-period adjustment with disclosure of 
the following in the period of its discovery and correction:
a. Nature of the error in previously issued financial statements? --------
b. Effect of its correction on revenue and gains in excess of expenses and losses 
(income) before extraordinary items and net revenue and gains in excess of 
expenses and losses (net income) (and related per share amounts if
applicable)? --------
[APB 20, par. 36 (AC A35.105); SFAS 109, par. 288n (AC A35.103)]
D. Financial Instruments
1. Except for certain excluded items (SFAS 105, pars. 14—15 (AC F25.104—.105)), 
are the following disclosed in the financial statements or notes for each class of 
financial instruments with off-balance-sheet risk:
a. The face or contract amount, or notional principal amount if there is no face
or contract amount? --------
b. The nature and terms, including, at a minimum, a discussion of:
(1) Credit and market risk of those instruments? --------
(2) Cash requirements of those instruments? --------
(3) Related accounting policy, as required by APB 22, Disclosure of
Accounting Policies (AC A10)? _____
[SFAS 105, par. 17 (CT F25.112)]
2. For financial instruments with off-balance-sheet credit risk (except for the items 
excluded in SFAS 105 (AC F25)), are the following disclosed, either in the 
financial statements or in the notes, by class of financial instrument:
a. The amount of accounting loss the entity would incur if any party to the
financial instrument failed completely to perform according to the terms of 
the contract and if the collateral or other security, if any, for the amount due 
proved to be of no value to the entity? _____
b. Regarding collateral or other security to support financial instruments subject 
to credit risk:
(1) The entity's policy of requiring such collateral or other security? _____
(2) Information about the entity's access to that collateral or other security? _____
(3) The nature and a brief description of the collateral or other security
supporting those financial instruments? --------
[SFAS 105, par. 18 (AC F25.113)]
3. Do disclosures of all significant concentrations of credit risk arising from all 
financial instruments, whether from an individual counterparty or groups of 
counterparties (except for certain insurance and investment contracts, purchase 
and pension obligations and substantively extinguished debt), include:
a. Information about the (shared) activity, region, or economic characteristic that
identifies the concentration? --------
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b. The amount of the accounting loss due to credit risk the entity would incur if 
any party to the financial instruments that make up the concentration failed 
completely to perform according to the terms of the contracts and if the 
collateral or other security, if any, for the amount due proved to be of no
value to the entity? _____
c. Regarding collateral or other security to support financial instruments subject 
to credit risk:
(1) The entity's policy of requiring such collateral or other security? _____
(2) Information about the entity's access to that collateral or other security? _____
(3) The nature and a brief description of the collateral or other security
supporting those financial instruments? _____
[SFAS 105, pars. 14 and 20 (AC F25.104 and .115)]
4. Is the fair value of financial instruments for which it is practicable to estimate that
value (except for certain excluded items and trade receivables and payables 
whose amount approximates fair value) disclosed in the financial statements or 
accompanying notes? _____
5. Are the methods and significant assumptions used to estimate the fair value of
financial instruments disclosed? _____
[SFAS 107, par. 10 (AC F25.115C)]
6. If it is not practicable to estimate the fair value of a financial instrument, are the 
following disclosed:
a. Information pertinent to estimating the fair value of that financial instrument
or class of financial instruments, such as the carrying amount, effective 
interest rate, and maturity? _____
b. The reasons why it is not practicable to estimate fair value? _____
[SFAS 107, par. 14 (AC F25.115G)]
E. Nonmonetary Transactions
1. Do disclosures include:
a. Nature of the transactions? _____
b. Basis of accounting for the assets transferred? _____
c. Gains or losses recognized on the transfers? _____
[APB 29, par. 28 (AC 01.102 and N35.120)]
F. Subsequent Events
1. Are the financial statements adjusted for any changes in estimates resulting from 
subsequent events that provide additional evidence about conditions that existed
at the balance-sheet date? _____
[SFAS 5, par. 8 (AC C59.105); SAS 1, secs. 560.03—.04, .07 and 561.01—.09 (AU 
560.03—.04, .07 and 561.01—.09)]
2. Are subsequent events that provide evidence about conditions that did not exist 
at the date of the balance sheet, but arose subsequent to that date, adequately
disclosed to keep the financial statements from being misleading? _____
[SFAS 5, par. 11 (AC C59.112); APB 16 (AC B50.120); SAS 1, secs. 560.05—. 07,
.09 and 561.01—.09 (AU 560.05—. 07, .09 and 561.01—.09)]
G. Pension Plans
1. If there is a defined benefit plan, do disclosures include:
a. A description of the plan, including employee groups covered, type of benefit
formula, funding policy, types of assets held and significant nonbenefit 
liabilities, if any, and the nature and effect of significant matters affecting 
comparability of information for all periods presented? _____
b. The amount of net periodic pension cost for the period showing separately 
the service cost component, the interest cost component, the actual return on
assets for the period, and the net total of other components? _____
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c. A schedule reconciling the funded status of the plan with amounts reported in 
the employer's balance sheet, showing separately:
(1) The fair value of plan assets?
(2) The projected benefit obligation identifying the accumulated benefit 
obligation and the vested benefit obligation?
(3) The amount of unrecognized prior-service cost?
(4) The amount of unrecognized net gain or loss (including asset gains and 
losses not yet reflected in market-related value)?
(5) The amount of any remaining unrecognized net obligation or net asset 
existing at the date of initial application of SFAS 87 (AC P16)?
(6) The amount of any additional liability recognized pursuant to SFAS 87, 
paragraph 36 (AC P16.130)?
(7) The amount of net pension asset or liability recognized in the balance 
sheet pursuant to SFAS 87, paragraphs 35—36 (AC P16.129—.130) 
(which is the net result of combining the preceding six items)?
d. The weighted-average assumed discount rate and rate of compensation 
increase (if applicable) used to measure the projected benefit obligation and 
the weighted-average expected long-term rate of return on plan assets?
e. If applicable, the amount and types of securities of the employer and related 
parties included in plan assets and the approximate amount of annual 
benefits of employees and retirees covered by annuity contracts issued by the 
employer and related parties (also, if applicable, the alternative amortization 
methods used pursuant to SFAS 87, paragraphs 26 and 33 (AC P16.120 and 
.127), and the existence and nature of the commitment discussed in paragraph 
41 (AC P16.135))?
[SFAS 87, par. 54 (AC P16.150)]
f. If more than one defined benefit plan exists:
(1) Are the disclosures required by Step H.1. above aggregated for all of the 
employee's single-employer defined benefit plans or disaggregated in 
groups so as to provide the most useful information?
(2) Are plans with assets in excess of accumulated benefit obligations not 
aggregated with plans that have accumulated benefit obligations that 
exceed plan assets?
[SFAS 87, par. 56 (AC P16.153)]
2. If there are one or more defined contribution plans, do disclosures include:
a. A description of the plans, including employee groups covered, the basis for 
determining contributions, and the nature and effect of significant matters 
affecting comparability of information for all periods presented?
b. The amount of cost recognized during the period?
[SFAS 87, par. 65 (AC P16.162)]
3. If the substance of a plan having characteristics of both defined benefits and 
contributions is to provide a defined benefit, are disclosures in accordance with 
the requirements applicable to a defined benefit plan as described in Step H.1. 
above?
[SFAS 87, par. 66 (AC P16.163)]
4. If there are one or more multiemployer plans, do disclosures include:
a. A description of the multiemployer plans, including the employee groups 
covered, the type of benefits provided (defined benefit or defined 
contribution), and the nature and effect of significant matters affecting 
comparability of information for all periods presented?
b. The amount of cost recognized during the period?
[SFAS 87, par. 69 (AC P16.166)]
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5. If there is a settlement and/or curtailment of a defined benefit pension plan and/ 
or termination of benefits under such plan, do disclosures include:
a. A description of the nature of the event(s)?
b. The amount of gain or loss recognized?
[SFAS 88, par. 17 (AC P16.187)]
H. Postretirement Benefits Other Than Pensions
1. If there are one or more defined benefit postretirement plans, do disclosures 
include:
a. A description of the substantive plans that is the basis for the accounting, 
including the nature of the plans, any modifications of the existing cost­
sharing provisions that are encompassed by the substantive plans, and the 
existence and nature of any commitment to increase monetary benefits 
provided by the plans, employee groups covered, types of benefits provided, 
funding policy, types of assets held and significant nonbenefit liabilities, and 
the nature and effect of significant matters affecting the comparability of 
information for all periods presented, such as the effect of a business 
combination or divestiture?
b. The amount of net periodic postretirement benefit cost showing separately 
the service cost component, the interest cost component, the actual return on 
plan assets for the period, amortization of the unrecognized transition 
obligation or transition asset, and the net total of other components?
c. A schedule reconciling the funded status of the plans with amounts reported 
in the employer's balance sheet, showing separately:
(1) The fair value of plan assets?
(2) The accumulated postretirement benefit obligation, identifying separately 
the portion attributable to retirees, other fully eligible plan participants, 
and other active plan participants?
(3) The amount of unrecognized prior-service cost?
(4) The amount of unrecognized net gain or loss (including plan asset gains 
and losses not yet reflected in market-related value)?
(5) The amount of any remaining unrecognized transition obligation or 
transition asset?
(6) The amount of net postretirement benefit asset or liability recognized in 
the balance sheet, which is the net result of combining the preceding five 
items?
d. The assumed health care cost trend rate(s) used to measure the expected cost 
of benefits covered by the plan (gross eligible changes) for the next year and a 
general description of the direction and pattern of change in the assumed 
trend rate(s) thereafter, together with the ultimate trend rate(s) and when the 
rate(s) is expected to be achieved?
e. The weighted average of the assumed discount rate(s) and rate(s) of 
compensation increase (for pay-related plans) used to measure the 
accumulated postretirement benefit obligation and the weighted average of 
the expected long-term rate(s) of return on plan assets and, for plans whose 
income is segregated from the employer's investment income for tax 
purposes, the estimated income tax rate(s) included in that rate of return?
f. The effect of a one-percentage-point increase in the assumed health care cost 
trend rates for each future year on:
(1) The aggregate of the service and interest cost components of net periodic 
postretirement health care benefit cost?
(2) The accumulated postretirement benefit obligation for health care benefits 
(for purposes of this disclosure, all other assumptions shall be held 
constant and the effects shall be measured based on the substantive plan 
that is the basis for the accounting)?
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g. The amounts and types of securities of the employer and related parties 
included in plan assets, and the approximate amount of future annual benefits 
of plan participants covered by insurance contracts issued by the employer 
and related parties?
h. Any alternative amortization method used?
i. The amount of gain or loss recognized during the period for a settlement or 
curtailment and a description of the nature of the event(s)?
j. The cost of providing special or contractual termination benefits recognized 
during the period and a description of the nature of the event(s)?
[SFAS 106, par. 74 (AC P40.169)]
2. If more than one defined benefit postretirement plan exists:
a. Are the disclosures aggregated for all of an employer's single-employer 
defined benefit postretirement plans or disaggregated in groups so as to 
provide the most useful information (except that the aggregate plan assets 
and the aggregate accumulated postretirement benefit obligation of the 
underfunded plans should be separately disclosed)?
[SFAS 106, par. 77 (AC P40.172)]
b. Are plans that primarily provide postretirement health care benefits and plans 
that primarily provide other postretirement welfare benefits separately 
disclosed if the accumulated postretirement benefit obligation of the latter 
plans is significant relative to the aggregate accumulated postretirement 
benefit obligation for all of the plans?
[SFAS 106, par. 78 (AC P40.173)]
3. If there is a multiemployer plan, do disclosures include:
a. A description of the multiemployer plan(s), including the employee groups 
covered, the type of benefits provided (defined benefit or defined 
contribution), and the nature and effect of significant matters affecting 
comparability of information for all periods presented?
b. The amount of postretirement benefit cost recognized during the period, if 
available (otherwise, the amount of the aggregate required contribution for 
the period to the general health and welfare benefit plan that provides health 
and welfare benefits to both active employees and retirees)?
[SFAS 106, par. 82 (AC P40.178)]
4. If there are one or more defined contribution postretirement plans, are the 
following items disclosed separately from defined benefit postretirement plan 
information:
a. A description of the plan(s), including employee groups covered, the basis for 
determining contributions, and the nature and effect of significant matters 
affecting comparability of information for all periods presented?
b. The amount of cost recognized during the period?
[SFAS 106, par. 106 (AC P40.198)]
I. Lessors
1. Are lessor disclosures appropriate and adequate?
[SFAS 13, pars. 23, 29 and 47; SFAS 91, par. 25d (AC L10.119 .125 and .149)]
J. Lessees
1. For capital leases do disclosures include:
a. Gross amounts of assets recorded by major classes, as of the date of each 
balance sheet presented?
b. Future minimum lease payments, as of the date of the latest balance sheet 
presented, in total and for each of the next five years, with separate 
deductions for executory costs and imputed interest to reduce net minimum 
lease payments to present value?
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c. Total future minimum sublease rentals under noncancelable subleases as of 
the date of the latest balance sheet presented?
d. Total contingent rentals actually incurred for each period presented?
e. Assets recorded under capital leases and the related accumulated 
amortization, and obligations under those leases identified separately in the 
balance sheet or a note?
[SFAS 13, pars. 13 and 16 (AC L10.112a)]
2. For operating leases that have initial or remaining noncancelable lease terms in 
excess of one year, do disclosures include:
a. Future minimum rental payments required as of the latest balance sheet 
presented in total and for each of the next five years?
b. Total future minimum rentals under noncancelable subleases as of the date of 
the latest balance sheet presented?
[SFAS 13, par. 16b (AC L10.112b)]
3. For all operating leases do disclosures include rental expense for each period 
presented, with separate amounts for minimum rentals, contingent rentals, and 
sublease rentals?
[SFAS 13, par. 16c (AC L10.112c)]
4. Do disclosures include a general description of the lessee's leasing arrangements 
including, but not limited to:
a. Bases for determination of contingent rentals?
b. Terms of any renewal or purchase options or escalation clauses?
c. Restrictive covenants?
[SFAS 13, par. 16d (AC L10.112d)]
K. Other Liabilities and Deferred Credits
1. If the entity is subject to income taxes:
a. Are deferred tax liabilities classified as current or noncurrent based on the 
related asset or liability for financial reporting?
[SFAS 109, par. 41 (AC I27.140)]
b. Are deferred tax liabilities not related to an asset or liability for financial 
reporting classified according to the expected reversal date of the temporary 
difference pursuant to SFAS 37?
[SFAS 109, par. 41 (AC I27.140)]
c. Are the following items offset and presented as a single amount for a 
particular tax-paying component and within a particular tax-paying 
jurisdiction:
(1) All current deferred tax liabilities and assets?
(2) All noncurrent deferred tax liabilities and assets?
[SFAS 109, par. 42 (AC I27.141)]
d. Are the components of the total of all deferred tax liabilities recognized in the 
balance sheet disclosed?
[SFAS 109, par. 43 (AC I27.142)]
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Exhibit A—Various
The effective date of SFAS 115 is for fiscal years beginning after December 15, 1993. 
It is to be initially applied as of the beginning of a fiscal year and cannot be applied 
retroactively to prior years' financial statements. An entity may elect to apply this 
statement as of the end of an earlier fiscal year for which annual financial statements 
have not previously been issued. Until such applications, the following disclosures 
remain in effect:
A. Consolidations and Combination
1. If the parent company includes realized gains or losses of marketable securities in 
net income and a consolidated subsidiary does not, is the subsidiary's accounting 
treatment for marketable securities conformed with that of the parent?
[SFAS 12, par. 18 (AC I89.112)]
2. If the parent follows specialized accounting practices for marketable securities 
and the consolidated subsidiaries do not, are the subsidiaries' current and 
noncurrent portfolios consolidated as separate current and noncurrent portfolios 
exclusive of the parent and is the information required by SFAS 12, paragraph 12, 
disclosed?
[SFAS 12, pars. 12 and 19 (AC I89.106 and .113)]
3. If the consolidated financial statements include more than one accepted practice 
of accounting for marketable securities, are the required disclosures for the 
various methods disclosed?
[SFAS 12, par. 20 (AC I89.114)]
B. Marketable Equity Securities
1. For marketable equity securities, do disclosures include:
a. For each balance sheet presented, aggregate cost and market value (each 
segregated between current and noncurrent portfolios when a classified 
balance sheet is presented) with identification as to which is the carrying 
amount?
b. For the latest balance sheet presented, gross unrealized gains and gross 
unrealized losses (each segregated between current and noncurrent portfolios 
when applicable)?
[SFAS 12, pars. 12b and 16a (AC I89.106b and .110a)]
c. For each period for which a statement of revenues and expenses (statement of 
operations) is presented:
(1) Net realized gain or loss included in the statement?
(2) Basis on which cost was determined in calculating realized gain or loss 
(such as average cost or FIFO)?
[AAG, par. 6.09; SFAS 12, pars. 12 and 16 (AC I89.106 and .110)]
2. Are significant net realized and net unrealized gains and losses that arose after 
the latest balance sheet date, but before issuance of the financial statements, 
disclosed?
[AAG, par. 6.10; SAS 1, sec. 560, pars. 5 and 7 (AU 560.05 and .07); SFAS 12, 
pars. 13 and 17 (AC 189.107 and .111); FASBI 11, pars. 3—4 (AC I89.115—.116); 
FASBI 13, pars. 5—7 (AC I89.120—.122)]
3. Are losses due to a change in classification of a marketable equity security 
between current and noncurrent reported in the statement of revenues and 
expenses?
[AAG, par. 6.12; SFAS 12, par. 10 (AC I89.104)]
4. For a portfolio included in current assets in the general funds, are changes in the 
valuation allowance disclosed and reported in the statement of revenues and 
expenses?
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5. For a portfolio included in noncurrent assets, or assets in unclassified balance 
sheets or restricted funds, are changes in the valuation allowance disclosed and 
reported in the respective statement of changes in fund balances or equity?
[AAG, par. 6.12; SFAS 12, par. 11 (AC I89.105)]
C. Financial Statement Presentation
1. For marketable equity securities, are the following disclosed for each period for 
which an income statement is presented:
a. Net realized gain or loss included in determination of net income?
[SFAS 12, par. 12c (AC I89.106c)]
b. For entities with certain specialized accounting practices, the change in net 
unrealized gain or loss?
[SFAS 12, par. 16b (AC I89.110b)]
c. Basis on which cost was determined in computing realized gain or loss?
[SFAS 12, par. 12c (AC I89.106c)]
d. The change in valuation allowance(s) during the period and when a classified 
balance sheet is presented and the amount of such change included in the 
determination of net income?
[SFAS 12, par. 12c (AC I89.106c)]
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FSP Section 21,400 
Auditors’ Reports Checklist
.01 This checklist has been developed by the staff of the Technical Information Division of the AICPA as a 
nonauthoritative practice aid.
.02 Explanation of References:
SAS = AICPA Statement on Auditing Standards
AU = Reference to section number in AICPA Professional Standards (vol. 1)
SSARS = FASB Statements on Standards for Accounting and Review Services
AR = Reference to section number in AICPA Professional Standards (vol. 2)
.03 Checklist Questionnaire
Yes No N/A
1. Does the auditor's report include appropriate:
a. Addressee? -------- -------- --------
[SAS 58, par. 9 (AU 508.09)]
b. Date (or dual dates) of the report? -------- -------- --------
[SAS 1, sec. 530.05 (AU 530.05)]
c. A title that includes the word "independent"? -------- -------- --------
[SAS 58, par.8a (AU 508.08a)]
2. If the auditor is not independent, is a compilation report the highest level of
service performed? -------- -------- --------
[SAS 26, par. 10 (AU 504.10); SSARS 1, pars. 22 and 38 (AR 100.22 and 38)]
3. Does the reporting language conform with the auditor's standard report on:
a. Financial statements of a single year or period? -------- -------- --------
b. Comparative financial statements? -------- -------- --------
[SAS 58, par. 8 (AU 508.08)
4. Does the report include appropriate language for the following situations:
a. Only one basic financial statement is presented and there are no scope
limitations? -------- -------- --------
[SAS 58, par. 47—48 (AU 508.47—.48)]
b. Audited and unaudited financial statements are presented in comparative
form? -------- -------- --------
[SAS 26, pars. 14—17 (AU 504.14—.17)]
5. Is an explanatory paragraph (or other explanatory language) added to the 
standard report if:
a. The financial statements are affected by uncertainties concerning future events, 
the outcome of which is not susceptible of reasonable estimation at the date
of the auditor's report? -------- -------- --------
[SAS 58, pars. 16—33 (AU 508.16—.33)]
Note: Consult the Topical Index to the AICPA Professional Standards under 
"Uncertainties" for additional references to specific types of uncertainties.
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b. There is substantial doubt about the entity's ability to continue as a going 
concern for a reasonable period of time and that conclusion is expressed 
through the use of the phrase "substantial doubt about its (the entity's) ability 
to continue as a going concern"?
[SAS 64, par. 1 (AU 341.12—.13)]
c. There is a material change between periods in accounting principles or in the 
method of their application?
[SAS 58, pars. 34—36 (AU 508.34—.36)]
d. In an updated report on comparative financial statements, the current opinion 
on the prior period is different from the one previously expressed?
[SAS 58, pars. 77—78 and 81—82 (AU 508.77—.78 and .81—.82)]
e. The prior period financial statements are audited by a predecessor auditor 
whose report is not presented?
[SAS 64, par. 2 (AU 508.83)]
f. The auditor's opinion is based in part on the report of another auditor?
[SAS 1, sec. 543 (AU 543); SAS 58, pars.12—13 (AU 508.12—.13)]
g. The financial statements contain a departure from a promulgated accounting 
principle when conformity with GAAP would result in a misleading 
presentation?
[SAS 58, pars. 14—15 (AU 508.14—.15)]
h. Other information in a document containing audited financial statements is 
materially inconsistent with information appearing in the financial 
statements?
[SAS 8, par. 4 (AU 550.04)]
i. The auditor decides to emphasize a matter in the report?
[SAS 58, par. 37 (AU 508.37); Interpretation 38 of SAS 1, sec. 410 (AU 
9410.17); Interpretation 1 of SAS 57 (AU 9342.03)]
6. Is a qualified opinion or disclaimer of opinion expressed if scope limitations 
preclude application of one or more auditing procedures considered necessary in 
the circumstances?
[SAS 58, pars. 40—45 (AU 508.40—.45); SAS 31, par. 22 (AU 326.23); SAS 19, 
par. 12 (AU 333.12)]
Note: Consult the Topical Index to the AICPA Professional Standards under 
"Scope of Audit—Limitations" for additional references to specific types of scope 
limitations that could result in either a qualified or disclaimer of opinion.
7. Is a qualified opinion or adverse opinion expressed if a lack of conformity with 
GAAP (including inadequate disclosure) is present?
[SAS 58, pars. 49—66 (AU 508.49—.66); SAS 32, par. 3 (AU 431.03)]
Note: Consult the Topical Index to the AICPA Professional Standards under 
"Departures from Established Principles," "Adverse Opinions," and "Qualified 
Opinions" for additional references to specific types of GAAP departures that 
could result in either a qualified or adverse opinion.
8. Is a qualified or adverse opinion expressed if the entity specifically requests the 
auditor to report on prior-period financial statements that are incomplete (e.g., 
prior-period totals only)?
[SAS 58, fn. 27 (AU 508, fn. 27)]
9. If a qualified opinion, adverse opinion, or disclaimer of opinion is expressed, are 
all the substantive reasons for the opinion or disclaimer disclosed and is the 
reporting language appropriately modified?
[SAS 58, pars. 39, 68—69 and 71 (AU 508.39, .68—.69, and .71)]
10. If the auditor is requested to audit Internal Revenue Form 990, "Return of 
Organizations Exempt from Income Tax," is the appropriate report prepared? 
[Interpretation 2 of SAS 62 (AU 9623.47—.54)]
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11. If information accompanies the basic financial statements and auditor's report in 
an auditor-submitted document, does the report on the accompanying 
information:
a. State that the audit is performed for the purpose of forming an opinion on the
basic financial statements taken as a whole? _____ _____ ____
b. Specifically identify the accompanying information? _____ _____ ____
c. State that the accompanying information is presented for purposes of
additional analysis and is not a required part of the basic financial statements? _____ _____ ____
d. State whether the accompanying information is subject to the auditing 
procedures applied in the audit of the basic financial statements and the
appropriate expression of opinion or disclaimer? _____ _____ ____
[SAS 29, pars. 6—11 (AU 551.06—.11)]
12. Is the reporting form and content of SAS 60, paragraphs 9—19, followed when
communicating internal control structure related matters noted in an audit?1 _____ _____ ____
1 Reportable conditions in internal control structure that have not been corrected must be communicated, preferably in writing, to senior 
management and the board of trustees or its audit committee. [SAS 60]
[SAS 60, pars. 9—19 (AU 325.09—.19)]
13. Is the reporting form and content of SAS 72 followed for comfort letters 
submitted to underwriters and other requesting parties on tax-exempt bond
offerings? _____ _____ ____
[SAS 72 (AU 634)]
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Auditors9Reports on Audits Performed Under 
Government Auditing Standards and OMB 
Circular A-133 Checklist1
1 On March 8, 1990, The Office of Management and Budget issued Circular A-133, Audits of Institutions of Higher Education and Other 
Nonprofit Organizations, to implement a "single audit" requirement for not-for-profit institutions. Circular A-133 requires that the auditor 
perform the audit in accordance with Government Auditing Standards (the "Yellow Book") issued by the Comptroller General of the United 
States.
Circular A-133, which supersedes the audit provisions of Circular A-110, is effective for audits of fiscal years beginning on or after January 1, 
1990. Because Circular A-133 permits biennial audits, some institutions may not be required to follow its requirements until the audits of their 
financial statements for the fiscal year ending June 30, 1992.
SAS No. 68, Compliance Auditing Applicable to Governmental Entities and Other Recipients of Governmental Financial Assistance, 
provides guidance on planning, performing, and reporting on the compliance aspects of audits in accordance with GAAS, GAO Standards, 
Circular A-133, and Circular A-128, which applies to State and Local Governmental entities.
On December 28, 1992, the AICPA issued SOP 92-9, Audits of Not-for-Profit Organizations Receiving Federal Awards, to provide guidance 
on the auditor's responsibilities when conducting an audit in accordance with Circular A-133. It incorporates the guidance in SAS 68, SOP 
92-7, OMB's October 1991 Compliance Supplement for Audits of Institutions of Higher Learning and Other Nonprofit Institutions, and the 
President's Council on Integrity and Efficiency Standards Subcommittee's Position Statement No. 6 (A-133 Questions and Answers).
2 See the checklist for auditor's reports on the basic financial statements.
.01 This checklist has been developed by the staff of the Technical Information Division of the AICPA as a 
nonauthoritative practice aid.
.02 This checklist has two parts: Part I is for reports on audits performed under Government Auditing 
Standards ("Yellow Book"). Part II contains the additional requirements for reports on audits performed in 
accordance with OMB Circular A-133. For audits performed under Circular A-133, both Parts I and II of this 
checklist must be completed.
.03 Explanation of References:
A-133 = Office of Management and Budget (OMB) Circular A-133
GAS = Government Auditing Standards ("Yellow Book," issued by GAO, 1988 Revision)
SAS = AICPA Statement on Auditing Standards
AU = Reference to section number in AICPA Professional Standards (vol. 1)
SOP 92-9 = AICPA Statement of Position, Audits of Not-for-Profit Organizations Receiving Federal 
Awards
.04 Checklist Questionnaire
Yes No N/A
Part I—Reports on Audits Performed in Accordance with Government
Auditing Standards (the “Yellow Book")
1. In an audit performed in accordance with the Yellow Book, are the following 
reports issued:
a. A report on the provider's basic financial statements? 2 _____ _____ _____
b. A report on internal control structure? _____ _____ _____
c. A report on compliance with laws and regulations that may have a direct and
material effect on the basic financial statements? _____ _____ _____
[SOP 92-9, par. 7.2]
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2. Does each auditor's report listed in Step 1. above contain a statement that the 
audit is conducted in accordance with generally accepted auditing standards and 
the Yellow Book?
[GAS, Ch. 5, par. 3; SOP 92-9, par. 7.4]
Report on Internal Control Structure 3
3. Does the report on internal control structure include, at a minimum:
a. The scope of the auditor's work to obtain an understanding of the internal 
control structure, and to assess control risk?
b. The significant internal controls established to ensure compliance with laws 
and regulations that have a material impact on the financial statements?
c. Any reportable conditions, including separate identification of material 
weaknesses, identified as a result of the auditor's work in understanding and 
assessing the control risk?
d. A statement that the report is intended for the information of the audit 
committee, management, and specific legislative or regulatory bodies, but 
that this restriction is not intended to limit the distribution of the report, if a 
matter of public record?
[GAS, Ch. 5, pars. 17 and 18; SAS 68, pars. 33 and 40 (AU 801.33 and .40); 
SOP 92-9, Appendix D, Exhibit D-3]
4. If the auditor notes reportable conditions in the financial statement audit, does 
the auditor's report on the internal control structure also contain:
a. The definition of reportable conditions?
b. A description of the reportable conditions noted?
c. The definition of material weakness?
d. If applicable, a statement that other matters involving the internal control 
structure and its operation were communicated to management in a separate 
letter?
[SAS 68, par. 40 (AU 801.40)]
5. If material weaknesses are noted in the report, does the auditor disclose the 
condition, cause, criteria, and effect of those material weaknesses?
[GAS, Chap. 5, par. 9, fn. 7]
6. If the auditor determines that deficiencies in the internal control structure are not 
significant enough to be considered reportable conditions (referred to as 
"nonreportable conditions"), are those matters communicated to the provider in 
writing (or orally, with working paper documentation)?
[SAS 68, par. 39 (AU 801.39); GAS Chap. 5, par. 25]
7. If the auditor issues a separate written communication describing nonreportable 
conditions, does the auditor's report on the internal control structure refer to that 
separate communication?
[SAS 68, pars. 38 and 39 (AU 801.38—.39); SOP 92-9, par. 7.12]
8. If no reportable conditions are noted during the audit, does the report disclose 
that no material weaknesses were identified?
[SAS 68, par. 42 (AU 801.42); SOP 92-9, par. 7.11]
Report on Compliance with Laws and Regulations
9. Does the report on compliance with laws and regulations conform to the standard 
report illustrated in SAS 68, paragraph 25 (AU 801.25)?
10. If the auditor decides not to test compliance with laws and regulations, does the 
report contain a statement that compliance with laws and regulations was not 
tested?
[SAS 68, par. 26 (AU 801.26); GAS, Chap. 5, par. 6]
3 Under the Yellow Book, a report on the internal control structure is required in all audits, even if no reportable conditions were noted. [SAS 
68, par. 33 (AU 801.33)]
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Yes
11. If the auditing procedures disclose material instances of noncompliance, is the
report on compliance appropriately modified? --------
a. Does that modified report include:
(1) The definition and identification of material instances of noncompliance
noted? _____
(2) A statement that the noncompliance noted was considered in forming an 
opinion on whether the provider's financial statements are presented
fairly, in conformity with GAAP? --------
[SAS 68, par. 27 (AU 801.27)]
12. If the report contains material instances of noncompliance, is a statement 
considered about:
a. Whether the misstatements were corrected? _____
or
b. The effect of such misstatements on the auditor's report on the basic financial
statements? --------
[SAS 68, par. 28 (AU 801.28)]
13. Are immaterial instances of noncompliance reported in a separate
communication to the provider? 4 --------
4 If there are no immaterial instances of noncompliance, the auditor may so note in the report. [SOP 92-9, par. 7.24]
[SAS 68, pars. 29 and 95 (AU 801.29 and .95); GAS, Chap. 5, par. 8]
14. If the auditor issues a separate letter describing immaterial instances of
noncompliance, does the compliance report include a reference to that letter? --------
[SAS 68, pars. 29 and 30 (AU 801.29 and .30); SOP 92-9, par. 7.16]
15. If the auditor becomes aware of illegal acts that could result in criminal
prosecution, are they communicated in a separate report to management? --------
[SAS 68, par. 31 (AU 801.31); GAS Chap. 5, par. 5]
16. If the auditor becomes aware of illegal acts and remains uncertain about whether 
they will materially affect the financial statements, is the report on the financial
statements qualified or a disclaimer of opinion issued? --------
[SOP 92-9, par. 7.18]
Other Matters
17. If performance audits are required by contractual obligations, are findings
presented in accordance with the guidance in the Yellow Book? --------
[GAS, Ch. 2, pars. 6—10]
18. If the auditor is unable to follow an applicable standard and is unable to 
withdraw from the engagement, does the auditor disclose in the scope section of 
the report the fact that an applicable standard is not followed, the reasons 
therefor, and the known effect of not following the standard on the results of the
audit? --------
[GAS, Ch. 3, par. 27]
19. Does the auditor's report disclose the status of known but uncorrected significant 
or material findings and recommendations from prior audits that could have an
effect on the current audit objective? --------
[SAS 68, par. 20, fn. 10 (AU 801.20); GAS, Ch. 3, par. 41; SOP 92-9, par.7.41]
20. Does the auditor's report disclose in the scope section of the report audit scope
impairments and the known effects they might have on the results of the audit? --------
[GAS, Ch. 3, par. 42]
21. Does the auditor consider the impact of his or her report on the financial 
statements of the effects of noncompliance findings from other simultaneous
audits that may result in claims for refunds? --------
[SOP 92-9, par. 7.43; SFAS 5 (AC C59)]
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No N/A
Yes No N/A
22. Do the reports on the schedule of federal awards, compliance, and internal 
control structure carry the same date as the report on the basic financial 
statements?
[SOP 92-9, par. 7.27]
Part II—Reports on Audits Performed Under OMB Circular A-133
1. If the provider is subject to the requirements of Circular A-133, are the following 
additional reports issued:
a. A report on a supplementary schedule of the provider's federal awards? 5
b. A report on the internal control policies and procedures used to administer 
federal awards?
c. A report on compliance with specific laws and regulations that may have a 
direct and material effect on each major program?
d. A report on compliance with certain laws and regulations applicable to 
nonmajor programs? 6
e. A report on compliance with general requirements? 7 
[SOP 92-9, par. 7.19]
5 Under Circular A-133, a recipient or subrecipient of an award is required to prepare a schedule of federal awards. A sample schedule is 
presented in the Illustrative Financial Statements section of these checklists. [Attachment to Circular A-133, par. 15(c)(1), SOP 92-9, pars. 4.7 
and 7.20]
6 Under the Yellow Book, a report on the internal control structure is required in all audits even if no reportable conditions were noted. [SAS 
68, par. 33 (AU 801.33)]
7 A report on compliance with general requirements is required regardless of whether there are any major programs. [SOP 92-9, par. 7.25]
2. Does each auditor's report listed in Step 1. above contain a statement that the 
audit is conducted in accordance with generally accepted auditing standards; 
Government Auditing Standards, issued by the Comptroller General of the 
United States; and Office of Management and Budget (OMB) Circular A-133? 
[SOP 92-9, Appendix D, Exhibits D-8 through D-18]
3. Does the auditor's report on the provider's schedule of federal awards:
a. Identify major programs?
b. Show total expenditures for each program?
[A-133, item 15c(1)]
Report on Internal Control Structure
4. Does the report on internal control structure include:
a. A description of the scope of the auditor's work to test the internal control 
structure policies and procedures?
b. A description of the provider's significant control policies and procedures 
established to provide reasonable assurance that it is managing its federal 
awards in compliance with applicable laws and regulations?
[SOP 92-9, par. 7.22]
5. If the auditor determines that tests of controls are likely to be ineffective in 
preventing or detecting noncompliance, is that matter disclosed as a "reportable 
condition?"
[SOP 92-9, par. 7.23]
6. If the auditor limits his or her consideration of the internal control structure for 
any reason, are the circumstances disclosed in the report on the internal control 
structure?
[SOP 92-9, par. 7.23]
Report on Compliance With Specific Requirements Related to Major Programs
7. For audits of major programs, does the report on compliance with specific 
requirements conform to the standard report illustrated in SAS 68, paragraph 81 
(AU 801.81)?
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Yes
8. If the auditor is disclaiming an opinion due to a scope limitation:
a. Are the reasons indicated, in a separate paragraph, as to why the audit did
not comply with generally accepted auditing standards, Government 
Auditing Standards, or OMB Circular A-133? _____
b. Does the auditor state that the scope of the audit is not sufficient to warrant
the expression of an opinion? _____
c. Does the auditor disclose any reservations he or she has regarding compliance
with applicable laws and regulations? _____
[SAS 68, pars. 82 and 84 (AU 801.82 and .84)]
9. If the auditor expresses a qualified or adverse opinion due to material 
noncompliance on a major federal program, does the auditor state the basis for
such an opinion in the report? _____
[SAS 68, par. 85 (AU 801.85)]
10. If the auditing procedures disclose instances of noncompliance on major 
programs:
a. Did the resulting modification to the auditor's report on compliance consider 
factors that include:
(1) The number and types of instances of noncompliance? _____
(2) Determinability of questioned costs? _____
(3) Materiality of questioned costs? _____
b. If, after considering those factors, the auditor concludes that the instances of
noncompliance have a material effect on a federal program, is a qualified or 
adverse opinion issued? _____
or
c. If, after considering those factors, the auditor is unable to determine if the
instance of noncompliance could have a material effect on the program, does 
the report state noncompliance occurred but the effect on the programs 
presently cannot be determined? _____
d. Is the effect of uncertainties associated with federal programs on the basic
financial statements considered and, if necessary, is the report modified? _____
[SOP 92-9, par. 7.24]
11. If the auditor is unable to examine appropriate evidence to support the comply/
noncomply decision, is the report appropriately modified? _____
[SOP 92-9, par. 7.24]
Report on Compliance with General Requirements
12. Does the report on compliance with general requirements conform to the 
standard report illustrated in SAS 68, paragraph 52 (AU 801.52) and in Exhibits
D-15 through D-17 in Appendix D of SOP 92-9? _____
Report on Compliance Related to Nonmajor Programs
13. For nonmajor programs, does the report on compliance conform to the standard
report illustrated in SAS 68, paragraph 90 (AU 801.90) and in Exhibit D-18 in 
Appendix D of SOP 92-9? _____
General
14. Does the auditor's report on compliance with laws and regulations include, for 
each federal award:
a. An identification of total amounts questioned as a result of noncompliance? _____
b. Any corrective action recommended by the auditor? _____
[SOP 92-9, pars. 7.30 and 7.32]
15. Are any immaterial findings included either (1) in a schedule of findings and
costs or (2) in a separate communication to management? _____
[SOP 92-9, par. 7.30]
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No N/A
Yes No N/A
16. If the audit is biennial, are both years within the period covered? 
[SOP 92-9, par. 2.47]
42
FSP Section 21,600 
Illustrative Financial Statements
.01 The following illustrative auditors' reports and financial statements demonstrate the practical applications 
of the reporting practices discussed in the AICPA Audit and Accounting Guide, Audits of Providers of Health Care 
Services (the Guide). Specific types of health care organizations have been selected to illustrate a wide diversity of 
reporting practices; it is not intended that these illustrations represent either the only types of disclosure or the 
only statement formats that would be appropriate. Health Care Organizations are urged to develop financial 
statement formats that are appropriate for their individual circumstances while being consistent with the 
accounting and reporting practices discussed in the Guide.
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SAMPLE HOSPITAL
.02 Balance Sheets
(Disaggregated "Layered" Reporting Approach)
December 31, 19X7 and 19X6
Assets
General Funds
Current assets
Cash and cash equivalents..............
Assets whose use is limited— 
required for current liabilities
(notes 5, 7, and 8).........................
Patient accounts receivable, net of 
estimated uncollectibles of 
$2,500,000 in 19X7 and 
$2,400,000
in 19X6 (note 15)...........................
Estimated third-party payor
settlements—Medicare
(notes 3 and 15)...........................
Supplies, at lower of cost
(first-in, first-out) or market....
Other current assets.........................
Due from donor-restricted funds ..
Total current assets..................
Assets whose use is limited (notes 5, 
7, and 8)
By board for capital improvements 
By agreements with third-party 
payors for funded depreciation . 
Under malpractice funding 
arrangement—held by trustee .. 
Under indenture agreement— 
held by trustee...............................
Total assets whose use is
limited......................................
Less assets whose use is limited 
and that are required for current 
liabilities..........................................
Noncurrent assets whose use 
is limited..................................
Property and equipment, net (notes 
6 and 7)
Other assets
Prepaid pension cost (note 12)....
Deferred financing costs..................
Investment in affiliated company
(note 4).............................................
Total other assets......................
19X7 19X6 Liabilities and Fund Balances 19X7 19X6
Current liabilities
$ 3,103,000 $ 4,525,000 Current installments of long-term 
debt (note 7)....................................
Current portion of capital lease
$ 970,000 $ 1,200,000
970,000 1,300,000 obligations (note 7)...................... 500,000 550,000
Accounts payable............................. 2,217,000 2,085,000
Accrued expenses............................. 3,396,000 3,225,000
15,100,000 14,194,000
Estimated third-party payor 
settlements—Medicaid (note 2) . 2,143,000 1,942,000
Deferred third-party
reimbursement ............................. 200,000 210,000
441,000 600,000 Advances from third-party payors 
Current portion of estimated
122,000 632,000
1,163,000 938,000 malpractice costs (note 8)...........
Retainage and construction
600,000 500,000
321,000 403,000 accounts payable........................... 955,000 772,000
— 500,000
Due to donor-restricted funds .... 300,000 —
21,098,000 22,460,000
Total current liabilities........... 11,403,000 11,116,000
11,000,000 10,000,000
Deferred third-party
9,234,000 6,151,000 reimbursement ............................. 746,000 984,000
3,007,000 2,682,000 Estimated malpractice costs, net of 
current portion (note 8)................ 3,207,000 2,182,000
11,708,000 11,008,000
34,949,000 29,841,000 Long-term debt, excluding current
installments (note 7).................... 22,644,000 23,614,000
970,000 1,300,000 Capital lease obligations,
excluding current portion (note 
7)........................................................ 500,000 400,000
33,979,000 28,541,000 Fund balance...................................... 69,310,000 64,567,000
51,038,000 50,492,000
85,000 35,000
693,000 759,000
917,000
1,695,000
576,000
1,370,000
Commitments and contingent
liabilities (notes 3, 6, 8,12, and
$107,810,000 $102,863,000
13) ........................................
$107,810,000 $102,863,000
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SAMPLE HOSPITAL
.02 Balance Sheets—continued
(Disaggregated "Layered" Reporting Approach)
December 31, and 19X6
See accompanying notes to financial statements.
Assets 19X7 19X6
Donor-Restricted Funds
Specific-purpose funds
Cash......................................................$ 378,000 $ 378,000
Investments, at cost that 
approximates market .................. 728,000 455,000
Grants receivable ......................... 613,000 535,000
$ 1,719,000 $ 1,368,000
Plant replacement and expansion 
funds
Cash...................................................... 24,000 321,000
Investments, at cost that 
approximates market ..................
Pledges receivable, net of
252,000 165,000
estimated uncollectibles of 
$60,000 in 19X7 and $120,000 
in 19X6............................................. 132,000 380,000
Due from general funds.................. 150,000 —
$ 558,000 $ 866,000
Endowment funds
Cash...................................................... 1,253,000 653,000
Investments, net of $175,000 
valuation allowance in 19X7, 
market value $3,798,000 in
19X7 and $5,013,000 in 19X6 
(note 9)............................................. 3,856,000 5,320,000
Due from general funds.................. 150,000 100,000
$ 5,259,000 $ 6,073,000
Liabilities and Fund Balances 19X7 19X6
Accounts payable........................ ... $ 205,000 $ 72,000
Deferred grant revenue............... 92,000 —
Due to general funds.................... — 255,000
Fund balance................................. 1,422,000
$ 1,719,000
1,041,000
$ 1,368,000
Due to general funds.................. 345,000
Fund balance............................... 558,000 521,000
$ 558,000 $ 866,000
Fund balance............................... 5,259,000 6,073,000
$ 5,259,000 $ 6,073,000
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SAMPLE HOSPITAL
.03 Balance Sheets
(Aggregated Approach)
December 31, 19X7 and 19X6
46
Assets 19X7 19X6
Current assets
Cash and cash equivalents................$ 2,803,000 $ 5,025,000
Assets whose use is limited—re­
quired for current liabilities (notes
5,7 and 8)........................................... 1,267,000 1,372,000
Patient accounts receivable, net of
estimated uncollectibles of
$2,500,000 in 19X7 and
$2,400,000 in 19X6 (note 15) .... 15,100,000 14,194,000
Estimated third-party 
payor settlements 
—Medicare (notes 
3 and 15)........................................... 441,000 600,000
Supplies, at lower of
cost (first-in,
first-out) or market......................... 1,163,000 938,000
Other current assets............................. 321,000 403,000
Total current assets......................... 21,095,000 22,532,000
Assets whose use is limited 
or restricted (notes 5, 
7, 8 and 9)
By board for capital improvements . 11,000,000 10,000,000
By agreements with third-party
payors for funded depreciation .. 9,234,000 6,151,000
Under malpractice funding arrange­
ment—held by trustee.................. 3,007,000 2,682,000
Under indenture agreement—held
by trustee........................................... 11,708,000 11,008,000
By donors or grantors for specific
purposes............................................. 2,277,000 1,634,000
By donors for permanent endow­
ment funds........................................ 5,259,000 6,073,000
Total assets whose use is limited or
restricted............................................. 42,485,000 37,548,000
Less assets whose use is limited and 
that are required for current liabili­
ties............................................................ 1,267,000 1,372,000
Noncurrent assets whose use is lim­
ited or restricted............................... 41,218,000 36,176,000
Property and equipment, net (notes 5 
and 6)...................................................... 51,038,000 50,492,000
Other assets
Prepaid pension cost (note 12)......... 85,000 35,000
Deferred financing costs.................... 693,000 759,000
Investment in affiliated company
(note 4)............................................... 917,000 576,000
Total other assets............................. 1,695,000 1,370,000
$115,046,000 $110,570,000
__________Liabilities and Fund Balances__________ 19X7 19X6
Current liabilities
Current installments of long-term 
debt (note 7)........................................$ 970,000 $ 1,200,000
Current portion of capital lease obli­
gations (note 7) ............................... 500,000 550,000
Accounts payable ............................... 2,422,000 2,157,000
Accrued expenses....... 3,396,000 3,225,000
Estimated third-party payor settle­
ments—Medicaid (note 2). 2,143,000 1,942,000
Deferred third-party reimbursement 200,000 210,000
Advances from third-party payors.. 122,000 632,000
Current portion of
estimated malpractice
costs (note 8) .................................... 600,000 500,000
Retainage and construction ac­
counts payable.................................. 955,000 772,000
Advances and deferred revenue.... 92,000 —
Total current liabilities .................. 11,400,000 11,188,000
Deferred third-party reimbursement.. 746,000 984,000
Estimated malpractice costs, net of
current portion (note 8)...................... 3,207,000 2,182,000
Long-term debt, excluding current in­
stallments (note 7)............................... 22,644,000 23,614,000
Capital lease obligations, excluding
current installments (note 7).............. 500,000 400,000
Total liabilities............................. 38,497,000 38,368,000
Net assets
Unrestricted.......................................... 69,310,000 64,567,000
Temporarily restricted by donors/ 
grantors............................................... 1,980,000 1,562,000
Permanently restricted by donors .. 5,259,000 6,073,000
Total net assets............................. 76,549,000 72,202,000
Commitments and contingent lia­
bilities (notes 3, 6, 8,12 and 13)
$115,046,000 $110,570,000
SAMPLE HOSPITAL
04 Statements of Revenue and Expenses of General Funds 
Years Ended December 31, 19X7 and 19X6
Net patient service revenue (notes 3,7 and 15).....................................
Other revenue................................................................................................
Total revenue ....................................................................................
Expenses (notes 7, 8, 12, and 13)
Professional care of patients....................................................................
Dietary services .........................................................................................
General services.........................................................................................
Administrative services...........................................................................
Employee health and welfare.................................................................
Medical malpractice costs........................................................................
Depreciation and amortization of property and equipment............
Interest .........................................................................................................
Provision for bad debts.............................................................................
Total expenses....................................................................................
Income from operations.................................................................
Nonoperating gains (losses)
Unrestricted gifts and bequests (note 10).............................................
Loss on investment in affiliated company (note 4) ..........................
Income on investments of endowment funds...................................
Income on investments whose use is limited
By board for capital improvements...................................................
By agreements with third-party payors for funded depreciation 
Under indenture agreement...............................................................
Other investment income........................................................................
Nonoperating gains, net.................................................................
Revenue and gains in excess of expenses and losses............................
See accompanying notes to financial statements.
19X7 19X6
$92,656,000
6,010,000
98,666,000
$88,942,000
5,380,000
94,322,000
53,016,000
4,407,000
10,888,000
11,075,000
10,000,000
1,125,000
4,782,000
1,752,000
1,010,000
48,342,000
4,087,000
9,973,000
10,145,000
9,335,000
200,000
4,280,000
1,825,000
1,103,000
98,055,000 89,290,000
611,000 5,032,000
822,000
(37,000)
750,000
926,000
(16,000)
650,000
1,120,000
850,000
100,000
284,000
1,050,000
675,000
90,000
226,000
3,889,000 3,601,000
$ 4,500,000 $ 8,633,000
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SAMPLE HOSPITAL
.05 Statements of Changes in Fund Balances
Years Ended December 31, 19X7 and 19X6
19X7 19X6
See accompanying notes to financial statements.
Balances at beginning of year.............
Additions
Revenue and gains in excess of
. $64,567,000 $1,041,000 $ 521,000 $6,073,000 $56,679,000 $ 933,000 $ 501,000 $5,973,000
expenses and losses.......................
Gifts, grants, and bequests
. 4,500,000 — — — 8,633,000 — — —
(notes 10 and 11)............................ — 869,000 220,000 — — 558,000 290,000 —
Investment income............................
Net realized gain on sale
. — 62,000 20,000 — — 50,000 15,000 —
of investments.................................
Transfer to finance property
— — 100,000 — — — 20,000 100,000
and equipment additions............. 243,000 — (243,000) — 255,000 — (255,000) —
Deductions
4,743,000 931,000 97,000 — 8,888,000 608,000 70,000 100,000
Provision for uncollectible pledges 
Capital contribution to Sample
. — — 60,000 — — — 50,000 —
Health System (note 11)...............
Net realized loss on sale
. — — — — 1,000,000 — — —
of investments.................................
Unrealized loss on marketable
. — — — 639,000 — — — —
equity securities (note 9)............. — — — 175,000 — — — —
Transfer to other revenue............... — 550,000 — — — 500,000 — —
— 550,000 60,000 814,000 1,000,000 500,000 50,000 —
Balances at end of year......................... . $69,310,000 $1,422,000 $ 558,000 $5,259,000 $64,567,000 $1,041,000 $ 521,000 $6,073,000
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Donor-Restricted Funds Donor-Restricted Funds
General 
Funds
Specific- 
Purpose 
Funds
Plant 
Replacement 
and Expan­
sion Funds
Endowment 
Funds
General 
Funds
Specific- 
Purpose 
Funds
Plant 
Replacement 
and Expan­
sion Funds
Endowment 
Funds
SAMPLE HOSPITAL
.06 Statements of Cash Flows of General Funds (Direct Method) *
Years Ended December 31, 19X7 and 19X6
Cash flows from operating activities and gains and losses
Cash received from patients and third-party payors........................................
Cash paid to employees and suppliers................................................................
Other receipts from operations.............................................................................
Receipts from unrestricted gifts and bequests...................................................
Interest and dividends received.............................................................................
Interest paid (net of amount capitalized)...........................................................
Net cash provided by operating activities and gains and losses...............
Cash flows from investing activities
Purchase of property and equipment..................................................................
Transfer from donor-restrictea fund for purchase of property and
equipment..............................................................................................................
Investment in affiliated company.........................................................................
Transfer to Sample Health System......................................................................
Cash invested in assets whose use is limited.....................................................
Net cash used by investing activities ..............................................................
Cash flows from financing activities
Increase in retainage and construction accounts payable...............................
Repayment of long-term debt...............................................................................
Payments from donor-restricted funds related to temporary loans.............
Payments on capital lease obligations ................................................................
Temporary loans from (to) donor-restricted funds..........................................
Net cash used by financing activities..............................................................
Net increase (decrease) in cash and cash equivalents..........................................
Cash and cash equivalents at beginning of year...................................................
Cash and cash equivalents at end of year................................................................
See accompanying notes to financial statements.
19X7 19X6
$ 90,342,000
(89,214,000)
6,042,000
1,122,000
2,510,000
(1,780,000)
$ 85,619,000 
(81,510,000) 
5,563,000 
905,000
2,330,000
(1,856,000)
9,022,000 11,051,000
(4,728,000) (5,012,000)
243,000
(394,000)
(4,798,000)
255,000
(425,000)
(1,000,000)
(855,000)
(9,677,000) (7,037,000)
183,000
(1,200,000)
500,000
(550,000)
300,000
175,000
(1,630,000)
(600,000)
(193,000)
(767,000) (2,248,000)
(1,422,000)
4,525,000
1,766,000
2,759,000
$ 3,103,000 $ 4,525,000
* The direct and indirect methods of reporting cash flows by hospitals are presented for illustrative purposes. The indirect method is
presented on page 21,609.
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SAMPLE HOSPITAL
.06 Statements of Cash Flows of General Funds (Direct Method) *—continued
Years Ended December 31, 19X7 and 19X6
Reconciliation of Revenue and Gains in Excess of Expenses and Losses to Net
Cash Provided by Operating Activities and Gains and Losses
Revenue and gains in excess of expenses and losses........... .................................
Adjustments to reconcile revenue and gains in excess of expenses and
losses to net cash provided by operating activities and gains and losses
Depreciation and amortization of property and equipment......................
Provision for bad debts........................................................................................
Amortization of deferred financing costs.......................................................
Loss on investment in affiliated company.....................................................
Noncash gifts and bequests...............................................................................
Decrease in amounts due to third-party payors............................................
Increase in liability for estimated malpractice costs.....................................
Increase in patient accounts receivable...........................................................
Increase in supplies and other current assets................................................
Increase in accounts payable and accrued expenses...................................
Increase in interest earned but not received on assets whose use is
limited................................................................................................................
$ 9,022,000 $ 11,051,000
19X7 19X7
4,500,000 $ 8,633,000
4,782,000 4,280,000
1,010,000 1,103,000
66,000 45,000
53,000 —
— (175,000)
(398,000) (77,000)
1,125,000 200,000
(1,916,000) (3,141,000)
(193,000) (118,000)
303,000 301,000
(310,000) —
Net cash provided by operating activities and gains and losses
Supplemental Disclosures of Cash Flow Information
Sample Hospital entered into capital lease obligations of $600,000 for new equipment in 19X7. 
See accompanying notes to financial statements.
* The direct and indirect methods of reporting cash flows by hospitals are presented for illustrative purposes. The indirect method is
presented on page 21,609.
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SAMPLE HOSPITAL
.07 Statements of Cash Flows of General Funds (Indirect Method) *
Years Ended December 31, 19X7 and 19X6
Cash flows from operating activities and gains and losses
Revenue and gams in excess of expenses and losses........................................
Adjustments to reconcile revenue and gains in excess of expenses and
losses to net cash provided by operating activities and gains and losses
Depreciation and amortization of property and equipment..................
Provision for bad debts...................................................................................
Amortization of deferred financing costs...................................................
Loss on investment in affiliated company................................................
Noncash gifts and bequests...........................................................................
Decrease in net amounts due to third-party payors.................................
Increase in liability for estimated malpractice costs.................................
Increase in patient accounts receivable.......................................................
Increase in supplies and other current assets............................................
Increase in accounts payable and accrued expenses...............................
Increase in interest earned but not received on assets whose use is 
limited....................................................................................................................
Net cash provided by operating activities and gains and losses...........
Cash flows from investing activities
Purchase of property and equipment..................................................................
Transfer from donor-restricted fund for purchase of property and
equipment..............................................................................................................
Investment in affiliated company.........................................................................
Transfer to Sample Health System......................................................................
Cash invested in assets whose use is limited.....................................................
Net cash used by investing activities .............................................................
Cash flows from financing activities
Increase in retainage and construction accounts payable...............................
Repayment of long-term debt...............................................................................
Payments from donor-restricted funds related to temporary loans.............
Payments on capital lease obligation..................................................................
Temporary loans from (to) donor-restricted funds..........................................
Net cash used by financing activities..............................................................
Net increase (decrease) in cash and cash equivalents..........................................
Cash and cash equivalents at beginning of year...................................................
Cash and cash equivalents at end of year................................................................
19X7 19X6
$ 4,500,000 $ 8,633,000
4,782,000 4,280,000
1,010,000 1,103,000
66,000 45,000
53,000 —
— (175,000)
(398,000) (77,000)
1,125,000 200,000
(1,916,000) (3,141,000)
(193,000) (118,000)
303,000 301,000
(310,000) —
9,022,000 11,051,000
(4,728,000) (5,012,000)
243,000 255,000
(394,000) (425,000)
— (1,000,000)
(4,798,000) (855,000)
(9,677,000) (7,037,000)
183,000 175,000
(1,200,000) (1,630,000)
500,000 —
(550,000) (600,000)
300,000 (193,000)
(767,000) (2,248,000)
(1,422,000) 1,766,000
4,525,000 2,759,000
$ 3,103,000 $ 4,525,000
Supplemental Disclosures of Cash Flow Information
Sample Hospital entered into capital lease obligations of $600,000 for new equipment in 19X7.
Cash paid for interest (net of amount capitalized) in 19X7 and 19X6 was $1,780,000 and $1,856,000, 
respectively.
See accompanying notes to financial statements.
* The direct and indirect methods of reporting cash flows by hospitals are presented for illustrative purposes. The direct method is presented
on pages 21,607 and 21,608.
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SAMPLE HOSPITAL
.08 Notes to Financial Statements
December 31, 19X7 and 19X6
1. Summary of Significant Accounting Policies 
Organization
Sample Hospital (Hospital) is a not-for-profit acute care hospital. Effective June 30, 19X6, under a plan of 
reorganization, Sample Health System was formed as the parent holding company of the Hospital. In its 
capacity as sole member of the Hospital, Sample Health System has the right to appoint Hospital trustees, 
approve major Hospital expenditures, and approve long-term Hospital borrowings.
Charity care
The Hospital provides care to patients who meet certain criteria under its charity care policy without charge or 
at amounts less than its established rates. Because the Hospital does not pursue collection of amounts 
determined to qualify as charity care, they are not reported as revenue.
Income taxes
The Hospital is a not-for-profit corporation as described in Section 501(c)(3) of the Internal Revenue Code 
and is exempt from federal income taxes on related income pursuant to Section 501(a) of the Code.
Net patient service revenue
Net patient service revenue is reported at the estimated net realizable amounts from patients, third-party 
payors, and others for services rendered, including estimated retroactive adjustments under reimbursement 
agreements with third-party payors. Retroactive adjustments are accrued on an estimated basis in the period 
the related services are rendered and adjusted in future periods as final settlements are determined. 
Investments and investment income
Donated investments are reported at fair value at the date of receipt, which is then treated as cost. Marketable 
equity securities included in investment portfolios are carried at the lower of aggregate cost (determined on an 
average-cost basis) or market at the balance sheet date. Other marketable securities are stated at cost, adjusted 
for impairments in value that are deemed to be other than temporary. Sample Hospital's investment in 
Affiliated Company is reported on the equity method of accounting that approximates Sample Hospital's 
equity in the underlying net assets of Affiliated Company.
Investment income on proceeds of borrowings that are held by a trustee, to the extent not capitalized, and 
investment income on assets deposited in the malpractice trust are reported as other revenue. Investment 
income from all other general fund investments and investment income of endowment funds are reported as 
nonoperating gains. Investment income and gains (losses) on investments of donor-restricted funds are added 
to (deducted from) the appropriate restricted fund balance.
Pledges
Pledges, less an allowance for uncollectible amounts, are recorded as receivables in the year made. Un­
restricted pledges are reported in the statement of revenue and expenses of general funds; restricted pledges 
are reported as additions to the appropriate restricted fund balance.
Statement of revenue and expenses of general funds
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For purposes of display, transactions deemed by management to be ongoing, major, or central to the 
provision of health care services are reported as revenues and expenses. Peripheral or incidental transactions 
are reported as gains and losses.
Costs of borrowing
Interest cost incurred on borrowed funds during the period of construction of capital assets is capitalized as a 
component of the cost of acquiring those assets.
Deferred financing costs are amortized over the period the obligation is outstanding using the interest 
method.
Amortization of deferred financing costs is capitalized during the period of construction of capital assets. 
Donor-restricted funds
Donor-restricted funds are used to differentiate resources, the use of which is restricted by donors or grantors, 
from resources of general funds on which donors or grantors place no restriction or that arise as a result of the 
operations of the Hospital for its stated purposes. Restricted gifts and other restricted resources are recorded 
as additions to the appropriate restricted fund.
Resources restricted by donors for plant replacement and expansion are added to the general fund balance to 
the extent expended within the period.
Resources restricted by donors or grantors for specific operating purposes are reported in other operating 
revenue to the extent used within the period.
Assets whose use is limited
Assets whose use is limited include assets set aside by the Board of Trustees for future capital improvements, 
over which the Board retains control and may at its discretion subsequently use for other purposes; assets set 
aside in accordance with agreements with third-party payors; and assets held by trustees under indenture 
agreements and self-insurance trust arrangements.
Property and equipment
Property and equipment acquisitions are recorded at cost. Property and equipment donated for hospital 
operations are recorded as additions to the donor-restricted plant replacement and expansion funds at fair 
value at the date of receipt and as transfers to the general fund balance when the assets are placed in service.
Depreciation is provided over the estimated useful life of each class of depreciable asset and is computed on 
the straight-line method. Equipment under capital leases is amortized on the straight-line method over the 
shorter period of the lease term or the estimated useful life of the equipment. Such amortization is included in 
depreciation and amortization in the financial statements.
An accelerated method for depreciating certain operating equipment acquired before 1970 has been elected 
for third-party reimbursement purposes. Third-party reimbursement is deferred to the extent of the effect of 
the difference between accelerated depreciation used for reimbursement reporting and straight-line deprecia­
tion used for financial reporting.
Cash and cash equivalents
Cash and cash equivalents include investments in highly liquid debt instruments with a maturity of three 
months or less, excluding amounts whose use is limited by board designation or other arrangements under 
trust agreements or with third-party payors.
Estimated malpractice costs
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The provision for estimated self-insured medical malpractice claims includes estimates of the ultimate costs 
for both reported claims and claims incurred but not reported.
2. Charity Care
The Hospital maintains records to identify and monitor the level of charity care it provides. These records 
include the amount of charges foregone for services and supplies furnished under its charity care policy, the 
estimated cost of those services and supplies, and equivalent service statistics. The following information 
measures the level of charity care provided during the years ended December 31, 19X7 and 19X6.
19X7 19X6
Charges foregone, based on established rates ......................................................... $6,000,000 $5,700,000
Estimated costs and expenses incurred to provide charity care .......................... 5,600,000 5,000,000
Equivalent percentage of charity care patients to all patients served ............... 5.7% 5.6%
3. Net Patient Service Revenue
The Hospital has agreements with third-party payors that provide for payments to the Hospital at amounts 
different from its established rates. A summary of the payment arrangements with major third-party payors 
follows.
• Medicare. Inpatient acute care services rendered to Medicare program beneficiaries are paid at prospec­
tively determined rates per discharge. These rates vary according to a patient classification system that is 
based on clinical, diagnostic, and other factors. Inpatient nonacute services, certain outpatient services, 
and defined capital and medical education costs related to Medicare beneficiaries are paid based upon a 
cost reimbursement methodology. The Hospital is reimbursed for cost reimbursable items at a tentative 
rate with final settlement determined after submission of annual cost reports by the Hospital and audits 
thereof by the Medicare fiscal intermediary. The Hospital's classification of patients under the Medicare 
program and the appropriateness of their admission are subject to an independent review by a peer 
review organization under contract with the Hospital. The Hospital's Medicare cost reports have been 
audited by the Medicare fiscal intermediary through December 31, 19X6.
• Medicaid. Inpatient and outpatient services rendered to Medicaid program beneficiaries are reimbursed 
under a cost reimbursement methodology. The Hospital is reimbursed at a tentative rate with final 
settlement determined after submission of annual cost reports by the Hospital and audits thereof by the 
Medicaid fiscal intermediary. The Hospital's Medicaid cost reports have been audited by the Medicaid 
fiscal intermediary through December 31, 19X6.
• Blue Cross. Inpatient services rendered to Blue Cross subscribers are reimbursed at prospectively 
determined rates per day of hospitalization. The prospectively determined per diem rates are not subject 
to retroactive adjustment.
The Hospital has also entered into payment agreements with certain commercial insurance carriers, health 
maintenance organizations, and preferred provider organizations. The basis for payment to the Hospital 
under these agreements includes prospectively determined rates per discharge, discounts from established 
charges, and prospectively determined daily rates.
4. Investment in Affiliated Company
In 19X2, the Hospital entered into an agreement with two unrelated hospitals to establish and operate an 
ambulatory care center, Affiliated Company (Center). In accordance with this agreement, each hospital 
invested $970,000 for a 33⅓ percent equity interest in the common stock of the Center. The investment was 
made in installments during the years 19X5 through 19X7, and in May 19X7 the Center began operations. The 
investment is recorded on the equity method.
Summarized financial information from the unaudited financial statements of the Center follows.
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December 31, 19X7 December 31, 19X6
Current assets .........
Noncurrent assets .. 
Current liabilities ... 
Noncurrent liabilities 
Shareholders' equity
Revenue 
Net loss
.. $1,779,000 $1,835,000
.. 4,052,000 4,007,000
.. 1,566,000 1,325,000
.. 1,514,000 2,789,000
.. 2,751,000 1,728,000
Year Ended
December 31, 19X7 December 31, 19X6
.. $3,220,000 $2,899,000
(111,000) (48,000)
Assets Whose Use Is Limited
Assets whose use is limited that are required for obligations classified as current liabilities are reported in 
current assets. The composition of assets whose use is limited at December 31, 19X7 and 19X6, is set forth in 
the following table. Investments are stated at cost that approximates market.
19X7 19X6
By board for capital improvements 
Cash and short-term investments $11,000,000 $10,000,000
By agreements with third-party payors for funded depreciation
Cash and short-term investments ....................................................................
U.S. Treasury obligations....................................................................................
Interest receivable.................................................................................................
$ 8,503,000 $ 5,712,000
316,000 316,000
415,000 123,000
$ 9,234,000 $ 6,151,000
Under malpractice funding arrangement—held by trustee
Cash and short-term investments ....................................................................
U.S. Treasury obligations....................................................................................
$ 1,058,000 $ 857,000
1,949,000 1,825,000
$ 3,007,000 $ 2,682,000
Under indenture agreement—held by trustee
Cash and short-term investments ....................................................................
U.S. Treasury obligations....................................................................................
Interest receivable.................................................................................................
$ 592,000 $ 1,260,000
11,024,000 9,674,000
92,000 74,000
$11,708,000 $11,008,000
Property and Equipment
A summary of property and equipment at December 31, 19X7 and 19X6, follows.
19X7 19X6
Land.............................................................................................................................
Land improvements .................................................................................................
Buildings and improvements.................................................................................
Equipment..................................................................................................................
Equipment under capital leases.............................................................................
Less accumulated depreciation and amortization ............................................
Construction in progress ........................................................................................
Property and equipment, net.............................................................................
$ 3,000,000 
472,000 
46,852,000 
29,190,000 
2,851,000
82,365,000
34,928,000
47,437,000
3,601,000
$51,038,000
$ 3,000,000 
472,000 
46,636,000 
26,260,000 
2,752,000
79,120,000
30,661,000
48,459,000
2,033,000
$50,492,000
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Construction contracts of approximately $7,885,000 exist for the remodeling of Hospital facilities. At Decem­
ber 31, 19X7, the remaining commitment on these contracts approximated $4,625,000.
7. Long-Term Debt and Capital Leases
A summary of long-term debt and capital leases at December 31, 19X7 and 19X6, follows,
19X7
9.25% Revenue Notes, due November 1, 19XX, collateralized by a pledge 
of the Hospital's gross receipts .........................................................................$21,479,000
9.25% mortgage loan, due January 19XX, collateralized by a mortgage on 
property and equipment with a depreciated cost of $1,800,000 at 
December 31, 19X7.............................................................................................. 2,010,000
9.75% note payable, due March 19XX, unsecured .......................................... 125,000
Total long-term debt........................................................................................ 23,614,000
Less current installments of long-term debt....................................................... 970,000
Long-term debt excluding current installments ....................................... $22,644,000
Capital lease obligations, at varying rates of imputed interest from 9.8% to 
12.3%, on leased equipment with an amortized cost of $1,500,000 at 
December 31, 19X7 .............................................................................................. 1,000,000
Less current portion of capital lease obligations .............................................. 500,000
Capital lease obligations, excluding current portion ........................................$ 500,000
19X6
$22,016,000
2,127,000
671,000
24,814,000
1,200,000
$23,614,000
950,000
550,000
$ 400,000
Under the terms of the Revenue Note Indenture, the Hospital is required to maintain certain deposits with a 
trustee. Such deposits are included with assets whose use is limited in the financial statements. The Revenue 
Note Indenture also places limits on the incurrence of additional borrowings and requires that the Hospital 
satisfy certain measures of financial performance as long as the notes are outstanding.
Scheduled principal repayments on long-term debt and payments on capital lease obligations for the next five 
years are as follows:
Long-Term
Debt
19X8
19X9
19Y0
19Y1
19Y2
$ 970,000 
912,000 
983,000 
1,060,000 
1,143,000
$5,068,000
Obligations Under 
Capital Leases
$ 500,000 
260,000 
260,000 
95,000
Less amount representing interest on obligations under capital 
leases .......................................................................................................
1,115,000
115,000
$1,000,000
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A summary of interest cost and investment income on borrowed funds held by the trustee under the Revenue 
Note Indenture during 19X7 and 19X6 follows.
19X7 19X6
Interest cost
Capitalized .......................................................................................................
Charged to operations ...................................................................................
Investment income
Capitalized .......................................................................................................
Credited to other revenue .............................................................................
$ 740,000 
1,752,000
$2,492,000
505,000
330,000
$ 835,000
$ 740,000 
1,825,000
$2,565,000
663,000
386,000
$1,049,000
8. Medical Malpractice Claims
The Hospital is uninsured with respect to medical malpractice risks. Losses from asserted claims and from 
unasserted claims identified under the Hospital's incident reporting system are accrued based on estimates 
that incorporate the Hospital's past experience, as well as other considerations including the nature of each 
claim or incident and relevant trend factors. Accrued malpractice losses have been discounted at rates ranging 
from 7 percent to 9 percent. No accrual for possible losses attributable to incidents that may have occurred but 
that have not been identified under the incident reporting system has been made because the amount is not 
reasonably estimable.
The Hospital has established an irrevocable trust fund for the payment of medical malpractice claim 
settlements. Professional insurance consultants have been retained to assist the Hospital with determining 
amounts to be deposited in the trust fund.
9. Endowment Funds—Investments
Donor-restricted endowment fund investment portfolios include marketable equity securities that are carried 
at the lower of cost or market. Marketable equity securities of endowment funds at December 31, 19X7 and 
19X6, are summarized as follows:
$50,000 in 19X6.
Cost
Quoted Market 
Value
Gross Unrealized 
Gains
Gross Unrealized
Losses
19X7 ......... ...............................$1,476,000 $1,301,000 $ 8,000 $183,000
19X6 ......... ............................... 1,620,000 1,832,000 228,000 16,000
Realized gains on marketable equity securities of endowment funds amounted to $10,000 in 19X7 and
10. Assets Held in Trust
The Hospital is an income beneficiary of the Thomas A. Smith Trust. Because the assets of the trust are not 
controlled by the Hospital, they are not included in the Hospital's financial statements. At December 31, 
19X7, the market value of the assets totaled approximately $2,652,000. Distributions of income are made at 
the discretion of the trustees. Income distributed to the Hospital by the trust is restricted for construction or 
equipment additions and amounted to $150,000 in 19X7 and $140,000 in 19X6.
11. Related Party Transactions
Because of the existence of common trustees and other factors, the Hospital and Sample Health Foundation 
(Foundation) are related parties. The Foundation is authorized by the Hospital to solicit contributions on its 
behalf. In its general appeal for contributions to support the community's providers of health care services,
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the Foundation also solicits contributions for certain other health care institutions. In the absence of donor 
restrictions, the Foundation has discretionary control over the amounts, timing, and use of its distributions.
Contributions made by the Foundation to the Hospital during the years ended December 31, 19X7 and 19X6, 
are reported in the Hospital's financial statements as follows:
19X7 19X6
Unrestricted gifts and bequests ............................................................................. $375,000 $525,000
Restricted contributions for—
Specific purposes................................................................................................. 300,000 200,000
Plant replacement and expansion .................................................................. 70,000 85,000
In addition, the Hospital made a capital contribution of $1,000,000 to Sample Health System during 19X6.
12. Pension Plan
The Hospital has a defined benefit pension plan covering substantially all of its employees. The plan benefits 
are based on years of service and employee compensation during the last five years of covered employment. 
The Hospital makes annual contributions to the plan equal to the amounts of net periodic pension cost. 
Contributions are intended to provide not only for benefits attributed to service to date but also for those 
expected to be earned in the future.
The actuarially computed net periodic pension cost for 19X7 and 19X6 included the following components:
19X7 19X6
Service cost-benefits earned during the period ............................................
Interest cost on projected benefit obligation ................................................
Actual return on plan assets .............................................................................
Net amortization and deferral...........................................................................
$ 905,000 
700,000 
(950,000) 
70,000
$ 770,000 
650,000
(800,000)
80,000
Net periodic pension cost $ 725,000 $ 700,000
Assumptions used in the accounting for net periodic pension cost were as follows:
As of December 31
Actuarial present value of benefit obligations
Vested benefit obligation .................................................................................
Nonvested benefit obligation...........................................................................
Accumulated benefit obligation..................................................................
Effect of projected future compensation levels........................................
Projected benefit obligation .........................................................................
Plan assets at fair value (primarily listed stocks and U.S. bonds)...............
Plan assets in excess of projected benefit obligation ..........................
Unrecognized net gain from past experience different from that assumed 
Prior service cost not yet recognized in net periodic pension cost...........
Unrecognized net asset at January 1, 19X6, being recognized 
over 15 years .....................................................................................................
Prepaid pension cost, included in other assets in the balance sheet ....
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The following table sets forth the plan's funded status and amounts recognized in the Hospital's financial 
statements at December 31, 19X7 and 19X6.
19X7 19X6
. $ 8,020,000 $ 6,800,000 
. 1,900,000 1,930,000
9,920,000 8,730,000
. 1,000,000 980,000
. 10,920,000 9,710,000
. 11,050,000 9,800,000
. 130,000 90,000
(30,000) (40,000)
50,000 55,000
. (65,000) (70,000)
. $ 85,000 $ 35,000
19X7 19X6
Discount rates .................................................................................................................. 7.0% 7.0%
Rates of increase in compensation levels .................................................................. 6.0 6.0
Expected long-term rate of return on assets ............................................................. 8.0 8.0
13. Commitments
Leases that do not meet the criteria for capitalization are classified as operating leases with related rentals 
charged to operations as incurred.
The following is a schedule by year of future minimum lease payments under operating leases as of December 
31, 19X7, that have initial or remaining lease terms in excess of one year.
Year Ending Minimum Lease
December 31 Payments
19X8............................................................................................................................................. $ 517,000
19X9 ............................................................................................................................................. 506,000
19Y0 ............................................................................................................................................. 459,000
19Y1 ............................................................................................................................................. 375,000
19Y2 ............................................................................................................................................. 343,000
Total minimum lease payments.................................................................................................$2,200,000
Total rental expense in 19X7 and 19X6 for all operating leases was approximately $859,000 and $770,000, 
respectively.
14. Subsequent Event
On February 9, 19X8, the Hospital signed a contract in the amount of $1,050,000 for the purchase of certain 
real estate.
15. Concentrations of Credit Risk
The Hospital is located in Feeling, Illinois. The Hospital grants credit without collateral to its patients, most of 
whom are local residents and are insured under third-party payor agreements. Revenues from patients and 
third-party payors were as follows:
Medicare and Medicaid .................................................................................................
Blue Cross .........................................................................................................................
Other third-party payors
(none over 10%) .........................................................................................................
Patients .............................................................................................................................
19X7 19X6
20% 19%
20 19
27 26
33 36
100% 100%
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SAMPLE NURSING HOME, INC.
.09 Balance Sheets
December 31, 19X2 and 19X1
See accompanying notes to financial statements.
Assets 19X2 19X1 Liabilities and Shareholders' Equity 19X2 19X1
Current assets Current liabilities
Cash and cash equivalents $ 95,000 $ 129,000 Current maturities of long-term debt $ 50,000 $ 50,000
Investments, at cost that Accounts payable 78,000 52,000
approximates market 150,000 — Accrued expenses 175,000 188,000
Assets whose use is limited— Deposits from patients 50,000 45,000
required for current liabilities 50,000 50,000 Income taxes payable 74,000 15,000
Patient accounts receivable less Total current liabilities 427,000 350,000
allowance for doubtful accounts: 
19X2-$6,700; 19X1-$5,300 162,000 152,000
Estimated third-party payor
settlements 71,000 62,000
Interest receivable 7,000 —
Supplies 59,000 57,000 Deferred income tax liability 6,000 14,000
Prepaid expenses 3,000 2,000
Long-term debt, less current
Total current assets 597,000 452,000 maturities 1,700,000 1,750,000
Assets whose use is limited
Under indenture agreement—held
by trustee 176,000 153,000 Shareholders' equity
Common stock, $20 par value;
authorized 5,000 shares; issued
By board for capital improvements 47,000 47,000 and outstanding 3,500 shares 70,000 70,000
Total assets whose use is limited 223,000 200,000 Retained earnings 376,000 229,000
Less assets whose use is limited Total shareholders' equity 446,000 299,000
and that are required for current 
liabilities 50,000 50,000
Noncurrent assets whose use
is limited 173,000 150,000
Property and equipment
Land 205,000 205,000
Land improvements 37,000 32,000
Buildings 1,399,000 1,399,000
Furniture, fixtures, and equipment 228,000 189,000
1,869,000 1,825,000
Less accumulated depreciation 210,000 141,000
Property and equipment, net 1,659,000 1,684,000
Other assets
Note receivable
Bond issuance cost, net of
81,000 72,000
accumulated amortization of 
$38,000 in 19X2 and 
$32,000 in 19X1 42,000 48,000
Land held for investment 27,000 7,000
Total other assets 150,000 127,000 Total liabilities and shareholders'
Total assets $2,579,000 $2,413,000 equity $2,579,000 $2,413,000
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SAMPLE NURSING HOME, INC.
.10 Statements of Income and Retained Earnings
Years Ended December 31, 19X2 and 19X1
Net patient service revenue................................................................................................................
Other revenue........................................................................................................................................
Total revenue ...............................................................................................................................
Expenses
Nursing services...............................................................................................................................
Dietary services..................................................................................................................................
General services...............................................................................................................................
Administrative services..................................................................................................................
Interest.................................................................................................................................................
Provision for bad debts ..................................................................................................................
Depreciation......................................................................................................................................
Total expenses...............................................................................................................................
Income from operations..............................................................................................................
Nonoperating gains-interest and dividends...................................................................................
Income before provision for income taxes.............................................................................
Provision for income taxes..................................................................................................................
Net income....................................................................................................................................
Retained earnings at beginning of year..........................................................................................
Retained earnings at end of year.......................................................................................................
19X2 19X1
$2,163,000 $1,949,000
67,000 22,000
2,230,000 1,971,000
1,083,000 1,010,000
228,000 225,000
212,000 212,000
173,000 147,000
164,000 172,000
92,000 83,000
69,000 57,000
2,021,000 1,906,000
209,000 65,000
18,000 7,000
227,000 72,000
80,000 29,000
147,000 43,000
229,000 186,000
$ 376,000 $ 229,000
See accompanying notes to financial statements.
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SAMPLE NURSING HOME, INC.
.11 Statements of Cash Flows
Years Ended December 31, 19X2 and 19X1
19X2
Cash flows from operating activities and gains
Cash received from residents and third-party payors..............................................................
Cash received from others..............................................................................................................
Cash paid to employees and suppliers........................................................................................
Interest and dividends received.....................................................................................................
Interest paid ......................................................................................................................................
Taxes paid..........................................................................................................................................
Deposits received from patients ...................................................................................................
Deposits refunded to patients.......................................................................................................
Net cash provided by operating activities and gains...........................................................
Cash flows from investing activities
Purchase of land held for investment..........................................................................................
Purchase of other investments .....................................................................................................
Proceeds from sale of property.....................................................................................................
Additions to property and equipment ........................................................................................
Cash invested in assets whose use is limited.............................................................................
Increase in notes receivable............................................................................................................
$2,048,000
67,000
(1,679,000)
10,000
(160,000)
(29,000)
35,000
(30,000)
262,000
$1,796,000
22,000
(1,495,000)
10,000
(170,000)
(30,000)
15,000
(20,000)
128,000
(20,000)
(150,000)
(44,000)
(23,000)
(9,000)
Net cash used in investing activities........................................................................................ (246,000)
Cash flows from financing activities
Repayment of long-term debt....................................................................................................... (50,000)
Net cash used by financing activities...................................................................................... (50,000)
Net increase (decrease) in cash.......................................................................................................... (34,000)
Cash at beginning of year.................................................................................................................. 129,000
Cash at end of year................................................................................................................................$ 95,000
Reconciliation of Net Income to Net Cash Provided by Operating Activities and Gains
Net income.............................................................................................................................................
Adjustments to reconcile net income to net cash provided by
operating activities and gains
Depreciation..................................................................................................................................
Provision for bad debts ..............................................................................................................
Amortization..................................................................................................................................
Loss on disposal of property.....................................................................................................
Increase (decrease) in deferred income tax liability..............................................................
Net effect of changes in receivables, supplies, prepaid expenses,
accounts payable, accrued expenses, and deposits.........................................................
Net cash provided by operating activities and gains...........................................................
19X1
2,000
(79,000)
(77,000)
(50,000)
(50,000)
1,000 
128,000 
$ 129,000
43,000
57,000
83,000
6,000
11,000
7,000
(79,000) 
$ 128,000
147,000
69,000
92,000
6,000
(8,000)
(44,000) 
$ 262,000
See accompanying notes to financial statements.
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SAMPLE NURSING HOME, INC.
.12 Notes to Financial Statements
December 31, 19X2 and 19X1
1. Summary of Significant Accounting Policies
Sample Nursing Home, Inc. (Company) operates a 128-bed nursing home in Abacus, New State. A summary 
of the Company's significant accounting policies follows.
Income taxes
The provisions for income taxes are based on net income reported for financial reporting purposes. Deferred 
income taxes arise from temporary differences between financial and income tax reporting of various items 
(principally depreciation). Tax credits are treated as a reduction of the provision for income taxes in the year 
in which the credits arise.
Patient service revenue
Patient service revenue is reported at the estimated net realizable amounts from residents, third-party payors, 
and others for service rendered.
Revenue under third-party payor agreements is subject to audit and retroactive adjustment. Provisions for 
estimated third-party payor settlements are provided in the period the related services are rendered. 
Differences between the estimated amounts accrued and interim and final settlements are reported in 
operations in the year of settlement.
Assets whose use is limited
Assets set aside by the board of directors for capital improvements and assets limited as to use under terms of 
a note indenture are classified as assets whose use is limited.
Property and equipment
Property and equipment are recorded at cost. Depreciation is calculated on the straight-line method over the 
estimated useful lives of depreciable assets.
Bond issuance costs
Costs incurred in issuing bonds are being amortized over the term of the bonds using the straight-line 
method.
Cash and cash equivalents
Cash and cash equivalents include investments in highly liquid debt instruments with a maturity of three 
months or less, excluding amounts whose use is limited by board designation or note indenture.
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2. Assets Whose Use Is Limited
Assets whose use is limited under a note indenture agreement at December 31, 19X2 and 19X1, are 
summarized as follows:
U.S. Treasury obligations, at cost that approximates market........................................
Cash..........................................................................................................................................
Accrued interest income.......................................................................................................
19X2 19X1
$150,000 $130,000
23,000 21,000
3,000 2,000
$176,000 $153,000
Assets set aside by the board of directors for capital improvements consist of certificates of deposit, at a cost 
that approximates market.
3. Long-Term Debt
Long-term debt at December 31,19X2 and 19X1, was as follows:
19X2 19X1
9.5 percent notes payable to the City of Abacus, maturing $50,000 
annually through November 1, 19XX, with a final maturity of $1,000,000 
on November 1, 20XX.............................................................................................. . $1,750,000 $1,800,000
Less current maturities................................................................................................. 50,000 50,000
$1,700,000 $1,750,000
The notes are collateralized by a first-mortgage lien on all property and equipment of the Company and a 
security interest in all of its receipts. The note indenture requires the maintenance of certain deposits with a 
trustee, which are included in assets whose use is limited.
Future maturities of long-term debt as of December 31, 19X2, follow.
19X3...................................................................................................................................................
19X4...................................................................................................................................................
19X5...................................................................................................................................................
19X6...................................................................................................................................................
19X7...................................................................................................................................................
Thereafter..........................................................................................................................................
$ 50,000
50,000 
50,000 
50,000 
50,000 
1,500,000
Total $1,750,000
4. Income Taxes
The provisions for income taxes on earnings were as follows:
Current
Federal.............................................................................................................................
State .................................................................................................................................
Total current..............................................................................................................
Deferred
Federal.............................................................................................................................
State ..................................................................................................................................
Total deferred............................................................................................................
Total provision for income taxes...................................................................................
19X2 19X1
$72,000
2,000
74,000
$15,000
15,000
6,000 13,000
1,000
6,000 14,000
$80,000 $29,000
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A reconciliation between the "statutory" federal income tax rate and the effective rate in the statements of 
income is as follows:
19X2 19X1
Statutory tax rate.......................................................................................................................... 34% 40%
State taxes, net of federal benefit............................................................................................... 1 1
Effective tax rate............................................................................................................................ 35% 41%
5. Pension Plan
[The disclosures contained in this note would be similar to the disclosures contained in note 12 of Sample 
Hospital and therefore are not repeated here.]
6. Concentrations of Credit Risk
[The disclosures contained in this note would be similar to the disclosures contained in note 15 of Sample 
Hospital and therefore are not repeated here.]
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SAMPLE CONTINUING CARE RETIREMENT COMMUNITY
.13 Balance Sheets
December 31, 19X5 and 19X4
Assets 19X5 19X4 Liabilities and Fund Deficit 19X5 19X4
Current assets
Cash..........................................................
Accounts receivable (net of allow­
ance for doubtful accounts of 
$4,000 and $5,000 ...........................
$ 375,000
187,000
$ 330,000
197,000
Current liabilities
Current maturities of long-term debt
Accounts payable..................................
Accrued expenses..................................
Deposits on unoccupied units...........
$ 90,000
180,000 
161,000 
22,000
$ 77,000
174,000 
178,000 
40,000
Supplies...................................................
Prepaid expenses..................................
40,000
15,000
21,000
8,000 Total current liabilities.................... 453,000 469,000
Total current assets........................... 617,000 556,000
Assets whose use is limited
Under note agreement—investments 
By board for capital improvements— 
investments.............................................
2,130,000
100,000
1,753,000
65,000
Long-term debt, less current maturities 8,871,000 8,935,000
2,230,000 1,818,000 Refundable fees........................................ 59,000 144,000
Property and equipment
Land..........................................................
Land improvements.............................
Buildings and improvements..............
Furniture and equipment....................
557,000
205,000
14,573,000
752,000
557,000
203,000
14,564,000
698,000
Estimated obligation to provide future 
services and use of facilities in excess 
of amounts received or to be re­
ceived for such services...................... 88,000 100,000
Accumulated depreciation..................
16,087,000
1,194,000
16,022,000
742,000 Deferred revenue from advance fees .. 9,304,000 9,585,000
14,893,000 15,280,000
Deferred financing costs (net of accu­
mulated amortization of $28,000 
and $21,000)........................................... 83,000 90,000
Fund deficit................................................. (952,000) (1,489,000)
$17,823,000 $17,744,000 $17,823,000 $17,744,000
See accompanying notes to financial statements.
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SAMPLE CONTINUING CARE RETIREMENT COMMUNITY
.14 Statements of Revenue and Expenses and Changes in Fund Deficit
Years Ended December 31, 19X5 and 19X4
19X5 19X4
Revenue
Resident fees earned including amortization of deferred revenue from nonrefundable
advance fees of $935,000 and $915,000...............................................................................$ 3,946,000 $ 3,152,000
Patient revenue from nonresidents............................................................................................ 249,000 275,000
Investment income......................................................................................................................... 107,000 78,000
Other................................................................................................................................................. 75,000 68,000
4,377,000 3,573,000
Expenses
Resident care.................................................................................................................................... 649,000 566,000
Dietary............................................................................................................................................... 781,000 701,000
Health care...................................................................................................................................... 185,000 170,000
Plant ................................................................................................................................................. 491,000 421,000
General and administrative......................................................................................................... 436,000 445,000
Depreciation.................................................................................................................................... 452,000 447,000
Interest ............................................................................................................................................ 967,000 955,000
3,961,000 3,705,000
416,000 (132,000)
Decrease (increase) in obligation to provide future services and use of facilities to
current residents......................................................................................................................... 12,000 (82,000)
Income (loss) from operations............................................................................................ 428,000 (214,000)
Nonoperating gains—Contributions............................................................................................ 109,000 73,000
Revenue and gains in excess of (less than) expenses..................................................... 537,000 (141,000)
Fund deficit, beginning of year....................................................................................................... (1,489,000) (1,348,000)
Fund deficit, end of year.................................................................................................................. $ (952,000) $(1,489,000)
See accompanying notes to financial statements.
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SAMPLE CONTINUING CARE RETIREMENT COMMUNITY
.15 Statements of Cash Flows
Years Ended December 31, 19X5 and 19X4
19X5 19X4
$ 3,252,000 
75,000 
109,000 
107,000 
(2,589,000) 
(950,000)
$ 2,341,000 
68,000 
73,000 
78,000 
(2,042,000) 
945,000)
4,000 (427,000)
(65,000)
(412,000)
(250,000)
(238,000)
467,000
477,000 (21,000)
615,000
(46,000)
26,000
(77,000)
857,000
(52,000)
(307,000)
518,000 498,000
45,000
330,000
50,000
280,000
$ 375,000 $ 330,000
Cash flows from operating activities and nonoperating gains
Cash received from residents and third-party payors...........................................................
Other receipts from operations...................................................................................................
Investment income received.......................................................................................................
Contributions received..................................................................................................................
Cash paid to employees and suppliers......................................................................................
Interest paid....................................................................................................................................
Net cash provided (used) by operating activities and nonoperating gains.............
Cash flows from investing activities
Acquisition of property and equipment....................................................................................
Cash invested in assets whose use is limited...........................................................................
Assets whose use is limited used for acquisition of property and equipment..................
Net cash used by investing activities...............................................................................
Cash flows from financing activities
Proceeds from advance fees and deposits...............................................................................
Refunds of advance fees and deposits......................................................................................
Proceeds from issuance of long-term debt...............................................................................
Repayments of long-term debt
Net cash provided by financing activities.........................................................................
Net increase in cash...........................................................................................................................
Cash at beginning of year................................................................................................................
Cash at end of year ...........................................................................................................................
Reconciliation of Revenue and Gains in Excess of (Less Than) Expenses to Net Cash 
Provided (Used) by Operating Activities and Nonoperating Gains
Revenue and gains in excess of (less than) expenses ................................................................
Adjustments to reconcile revenue and gains in excess of (less than) expenses to net cash
provided (used) by operating activities and nonoperating gains
Amortization of advance fees............................................................................................
Loss (gain) on obligation to provide future services.....................................................
Depreciation and amortization..........................................................................................
Provision for bad debts .......................................................................................................
Net change in other assets and liabilities [details omitted for editorial brevity*] ..
Net cash provided (used) by operating activities and nonoperating
gains....................................................................................................................................
537,000 (141,000)
(935,000) (915,000)
(12,000) 82,000
459,000 475,000
3,000 3,000
(48,000) 69,000
$ 4,000 $ (427,000)
See accompanying notes to financial statements.
* FASB Statement 95, Statement of Cash Flows, paragraph 29 [AC C25.127], requires that "The reconciliation of net income to net cash flow
from operating activities ... shall separately report all major classes of reconciling items".
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SAMPLE CONTINUING CARE RETIREMENT COMMUNITY
.16 Notes to Financial Statements
December 31, 19X5 and 19X4
1. Summary of Significant Accounting Policies
Sample Continuing Care Retirement Community (CCRC) provides housing, health care, and other related 
services to residents through the operation of a retirement facility containing 249 apartments and a seventy- 
eight-bed health care facility. A summary of significant accounting policies follows.
Advance fees
Fees paid by a resident upon entering into a continuing care contract, net of the portion thereof that is 
refundable to the resident, are recorded as deferred revenue and are amortized to income using the straight- 
line method over the estimated remaining life expectancy of the resident.
Obligation to provide future services and use of facilities
CCRC annually calculates the present value of the net cost of future services and use of facilities to be 
provided to current residents and compares that amount with the balance of deferred revenue from advance 
fees. If the present value of the net cost of future services and use of facilities exceeds the deferred revenue 
from advance fees, a liability is recorded (obligation to provide future services and use of facilities to current 
residents) with the corresponding charge to income. The obligation is discounted at 9 percent, based on the 
expected long-term rate of return on government obligations.
Investments
Investments, which consist of U.S. Treasury obligations, are stated at cost, which approximates fair market 
value. Interest and investment income are recognized when earned.
2. Property and Equipment
Property and equipment are stated at cost. Donated property is recorded at its estimated fair value at date of 
receipt, which then is treated as cost. Depreciation is computed on the straight-line method based on the 
following estimated useful lives:
Land improvements ............................................................................................................................................... 20 years
Buildings and improvements............................................................................................................................... 40 years
Furniture and equipment........................................................................................................................................5-15 years
When assets are retired or otherwise disposed of, the cost and related accumulated depreciation are removed 
from the accounts, and any resulting gain or loss is recognized in income for the period. The cost of 
maintenance and repairs is expensed as incurred; significant renewals and betterments are capitalized.
3. Deferred Financing Costs
Deferred financing costs are being amortized using the interest method over the term of the related financing 
agreement.
4. Tax Status
CCRC is a not-for-profit corporation as described in Section 501(c)(3) of the Internal Revenue Code and is 
exempt from federal income taxes pursuant to Section 501(a) of the Internal Revenue Code.
5. Long-Term Debt
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19X5 19X4
Long-term debt at December 31, 19X5 and 19X4, is as follows:
10.75% mortgage note payable........................................
Notes payable to bank—unsecured.................................
Other......................................................................................
...................................$8,901,000
................................. 34,000
................................. 26,000
$8,965,000
14,000
33,000
Less current maturities.......................................................
8,961,000
................................. 90,000
9,012,000
77,000
$8,871,000 $8,935,000
The mortgage note is payable in consecutive monthly installments of principal and interest of $85,425 to May 
20XX. The note is collateralized by a first mortgage on property and equipment with a depreciated value at 
December 31, 19X5, of $14,893,000 and by a pledge of all operating revenue.
As required by the mortgage note agreement, CCRC established an initial debt service reserve fund of 
$1,000,000 at April 15, 19X3. All resident fees received thereafter, net of resident fee refunds and debt service 
payments not to exceed $300,000 annually in the first four years and $200,000 annually thereafter, are to be 
added to the debt service reserve fund until the total sum of $2,050,000 is accumulated. Since June 1, 19X4, 
CCRC is required to deliver to the Trustee $5,500 per month to establish maintenance reserves until the 
aggregate of such payments equals a residential unit reserve and a health care center reserve of $240,000 and 
$90,000, respectively. At December 31, 19X5, the trustee held investments aggregating $2,130,000. Such 
amount had been classified as assets whose use is limited.
Scheduled annual principal maturities of long-term debt for the next five years are as follows:
19X6............................................................................................................................................................................. $ 90,000
19X7 .............................................................................................................................................................................. 90,000
19X8 .............................................................................................................................................................................. 95,000
19X9 ................................................................................................................................................................................ 105,000
19Y0 ................................................................................................................................................................................ 105,000
6. Assets Whose Use Is Limited
[The disclosures contained in this note would be similar to the disclosures contained in Note 5 of Sample 
Hospital and therefore are not repeated here.]
7. Pension Plan
[The disclosures contained in this note would be similar to the disclosures contained in Note 12 of Sample 
Hospital and therefore are not repeated here.]
8. Concentrations of Credit Risk
[The disclosures contained in this note would be similar to the disclosures contained in Note 15 of Sample 
Hospital and therefore are not repeated here.]
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SAMPLE HOME HEALTH AGENCY
.17 Balance Sheets
December 31, 19X5 and 19X4
Assets 19X5 19X4 Liabilities and Fund Balance 19X5 19X4
Current assets Current liabilities
Cash and cash equivalents... $ 74,000 $ 41,000 Current maturities of long­
term debt (note 4).................... $ 13,000 $ 13,000
Investments...............................
Accounts receivable, net of
112,000 102,000
estimated uncollectibles of 
$61,000 in 19X5 and 
$30,000 in 19X4 .................. 752,000 476,000 Accounts payable....................
Accrued payroll and vacation
40,000 21,000
costs........................................
Estimated third-party payor
settlements (note 2).............
496,000 352,000
28,000 31,000
Advances from third-party
Other receivables.................... 27,000 22,000 payors........................................ 70,000 66,000
Total current assets.................. 965,000 641,000 Total current liabilities........... 647,000 483,000
Assets whose use is limited
(note 3)
Cash............................................ 35,000 35,000
Bank certificates of deposit .. 100,000 100,000
Equipment
135,000 135,000
Long-term debt less current 
maturities (note 4).................... 105,000 118,000
Medical and office equipment 56,000 39,000
Vehicles..................................... 50,000
106,000
37,000
76,000
Less accumulated
depreciation.......................... 45,000 24,000
Net equipment ....................
Deferred finance charges, net of
61,000 52,000
accumulated amortization of 
$15,000 in 19X5 and $10,000 
in 19X4........................................ 20,000 25,000 Fund balance................................. 429,000 252,000
$1,181,000 $853,000 $1,181,000 $853,000
See accompanying notes to financial statements.
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SAMPLE HOME HEALTH AGENCY
.18 Statements of Revenue and Expenses and Changes in Fund Balances
Years Ended December 31, 19X5 and 19X4
Net patient service revenue (note 2).................................................................................................
Other revenue........................................................................................................................................
Total revenue.........................................................................................................................
Expenses (note 5)
Professional care of patients .........................................................................................................
General and administrative............................................................................................................
■ Occupancy..........................................................................................................................................
Provision for bad debts ..................................................................................................................
Depreciation......................................................................................................................................
Interest.................................................................................................................................................
Total expenses.......................................................................................................................
Income from operations.......................................................................................................................
Nonoperating gains.............................................................................................................................
Contributions ....................................................................................................................................
Investment income...........................................................................................................................
Total nonoperating gains...................................................................................................
Revenue and gains in excess of expenses........................................................................................
Fund balance at beginning of year ..............................................................................................
Fund balance at end of year............................................................................................................
See accompanying notes to financial statements.
19X5 19X4
$4,042,000 $2,687,000
27,000 32,000
4,069,000 2,719,000
2,714,000
1,042,000
90,000
46,000
21,000
16,000
1,835,000
675,000
83,000
21,000
15,000
19,000
3,929,000 2,648,000
140,000 71,000
19,000 15,000
18,000 12,000
37,000 27,000
177,000 98,000
252,000 154,000
$ 429,000 $ 252,000
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SAMPLE HOME HEALTH AGENCY
.19 Statements of Cash Flows
Years Ended December 31, 19X5 and 19X4
19X5
Cash flows from operating activities and nonoperating gains
Cash received from customers and third-party payors......................................................... $ 3,721,000
Other receipts from operations................................................................................................... 22,000
Cash paid to employees and suppliers...................................................................................... (3,683,000)
Interest paid.................................................................................................................................... (11,000)
Nonoperating gains....................................................................................................................... 37,000
Net cash provided by operating activities and nonoperating gains...................... 86,000
Cash flows from investing activities
Purchase of equipment................................................................................................................ (30,000)
Purchase of investments.............................................................................................................. (10,000)
Net cash used by investing activities ........................................................................... (40,000)
Cash flows from financing activities
Payment of long-term debt.......................................................................................................... (13,000)
Net cash used by financing activities........................................................................... (13,000)
Net increase in cash and cash equivalents.................................................................................... 33,000
Cash and cash equivalents at beginning of year......................................................................... 41,000
Cash and cash equivalents at end of year....................................................................................$ 74,000
Reconciliation of Revenue and Gains in Excess of Expenses to Net Cash Provided
by Operating Activities and Nonoperating Gains
Revenue and gains in excess of expenses...................................................................................... 177,000
Adjustments to reconcile revenue and gains in excess of expenses to net cash provided
by operating activities and nonoperating gains
Provision for bad debts................................................................................................................ 46,000
Depreciation and amortization................................................................................................... 26,000
Increase in accounts receivable................................................................................................... (322,000)
Increase in other receivables....................................................................................................... (5,000)
Increase in accounts payable and accrued expenses.............................................................. 163,000
Decrease (increase) in estimated third-party receivables..................................................... (3,000)
Increase in advances from third-party payors......................................................................................4,000
Net cash provided by operating activities and nonoperating gains $ 86,000
19X4
$ 2,542,000 
32,000
(2,540,000)
(14,000)
27,000
47,000
(19,000)
(15,000)
(34,000)
13,000
28,000
$ 41,000
98,000
21,000
20,000
(150,000)
(2,000)
50,000
3,000
7,000
$ 47,000
See accompanying notes to financial statements.
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SAMPLE HOME HEALTH AGENCY
.20 Notes to Financial Statements
Years Ended December 31, 19X5 and 19X4
1. Summary of Significant Accounting Policies
Sample Home Health Agency (the Agency) was incorporated in 19X0 as a not-for-profit corporation. The 
Agency provides health and supportive services to individuals at their homes.
Charity care
The Agency has a policy of providing charity care to patients who are unable to pay. Such patients are 
identified based on financial information obtained from the patient and subsequent analysis. Since the 
Agency does not expect payment, estimated charges for charity care are not included in revenue.
Net patient service revenue
Net patient service revenue represents the estimated net realizable amounts from patients, third-party payors, 
and others for services rendered.
Income taxes
The Agency is a not-for-profit corporation as described in Section 501(c)(3) of the Internal Revenue Code and 
is exempt from federal income taxes on related income pursuant to Section 501(a) of the Code.
Assets whose use is limited
Assets set aside for board-designated purposes are classified as assets whose use is limited.
Investments
Investments consist of U.S. Treasury obligations at cost, which approximates market value.
Equipment
Equipment is recorded at cost. Depreciation is computed using the straight-line method over the estimated 
useful lives of the assets.
Cash and cash equivalents
Cash and cash equivalents include investments in highly liquid debt instruments with a maturity of three 
months or less, excluding amounts whose use is limited by board designation.
2. Third-Party Rate Adjustments and Revenue
Approximately 38 percent in 19X5 and 37 percent in 19X4 of net patient service revenue was derived under 
federal and state third-party reimbursement programs. These revenues are based, in part, on cost reimburse­
ment principles and are subject to audit and retroactive adjustment by the respective third-party fiscal 
intermediaries. In the opinion of management, retroactive adjustments, if any, would not be material to the 
financial position, results of operations or cash flows of the Agency.
3. Board-Designated Assets
The board of directors has designated cash and investments aggregating $135,000 to be used for future major 
capital improvements. Those assets are classified in the balance sheets as assets whose use is limited.
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4. Long-Term Debt
Long-term debt at December 31, 19X5 and 19X4, is as follows:
Note payable to bank, interest at 15%, collateralized by equipment with a 
depreciated cost in 19X5 of $42,000................................................................
Less current maturities..............................................................................................
Long-term debt, less current maturities..................................................................
19X5 19X4
$118,000
13,000
$105,000
$131,000
13,000
$118,000
Scheduled maturities of long-term debt at December 31, 19X5 are as follows:
19X6...................................................................................................................................................
19X7...................................................................................................................................................
19X8...................................................................................................................................................
19X9...................................................................................................................................................
19X0...................................................................................................................................................
Thereafter..........................................................................................................................................
$ 13,000 
13,000 
13,000 
13,000 
13,000 
53,000
Total $118,000
5. Pension Plan
[The disclosures contained in this note would be similar to the disclosures contained in note 12 of Sample 
Hospital.]
6. Charity Care
Charity care represented approximately 3 percent and 4 percent of visits in 19X5 and 19X4, respectively.
7. Concentrations of Credit Risk
[The disclosures contained in this note would be similar to the disclosures contained in note 15 of Sample 
Hospital.]
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SAMPLE HEALTH MAINTENANCE ORGANIZATION
.21 Balance Sheets
December 31, 19X5 and 19X4
Assets 19X5 19X4 Liabilities and Fund Balance_________19X5 19X4
Current assets Current liabilities
Unsecured 12% note
Cash..................................... . $ 2,000 $ 193,000 payable to a bank.............
Portion of long-term debt
$ - $ 44,000
Temporary cash payable within one year
241,000 109,000investments.................... . 2,935,000 828,000 (note 4)...............................
Premiums receivable......... . 358,000 407,000
Accounts payable—medical
2,245,000 1,471,000Other receivables............... . 263,000 261,000 services ...............................
Supplies............................... . 190,000 184,000
Other accounts payable and
Prepaid expenses............... . 197,000 99,000 accrued expenses............. 829,000 661,000
Total current assets .... . 3,945,000 1,972,000 Unearned premium revenue . 141,000 202,000
Total current liabilities........... 3,456,000 2,487,000
Property and equipment 
(notes 3 and 4).................... . 7,559,000 7,062,000
Less accumulated Long-term debt, less portion
depreciation and payable within one year
4,295,000 4,382,000amortization.................... . 1,803,000 1,436,000 (note 4)...................................
Commitments and
contingencies (notes 2 and
5,756,000 5,626,000 8)
State guaranty fund deposit 
(note 5)..................................... . 150,000 150,000 Fund balance............................. 2,118,000 900,000
Debt issuance costs, net of
accumulated amortization
of $42,000 in 19X5 and 
$39,000 in 19X4.................. 18,000 21,000
Total liabilities and fund
Total assets.......................... . $9,869,000 $7,769,000 balance............................... $9,869,000 $7,769,000
See accompanying notes to financial statements.
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SAMPLE HEALTH MAINTENANCE ORGANIZATION
.22 Statements of Revenue and Expenses and Changes in Fund Balances
Years Ended June 30, 19X5 and 19X4
19X5
Revenue
Premiums earned....................................................................................................................$27,682,000
Coinsurance........................................................................................................................... 689,000
Interest and other income................................................................................................... 242,000
28,613,000
Expenses
Contracted hospital, physician, and other services ..................................................... 12,749,000
Health centers—medical services...................................................................................... 10,116,000
Health centers—administration........................................................................................ 1,556,000
General administration....................................................................................................... 1,695,000
Membership services............................................................................................................ 527,000
Interest.................................................................................................................................... 385,000
Depreciation and amortization.......................................................................................... 367,000
27,395,000
Income from operations ................................................................................................. 1,218,000
Fund balance at beginning of year................................................................................... 900,000
Fund balance at end of year.............................................................................................. $ 2,118,000
19X4
$22,500,000
500,000
100,000
23,100,000
9,734,000
8,786,000
1,530,000
1,309,000
440,000
375,000
336,000
22,510,000
590,000
310,000
$ 900,000
See accompanying notes to financial statements.
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SAMPLE HEALTH MAINTENANCE ORGANIZATION
.23 Statements of Cash Flows
Years Ended June 30, 19X5 and 19X4
19X5
Cash flows from operating activities 
Cash received from premiums, stop-loss insurance recoveries, and
coinsurance .................................................................................................................. $ 28,969,000
Cash paid to employees and to providers of health care services........................ (26,405,000)
Interest received................................................................................................................ 230,000
Interest paid....................................................................................................................... (382,000)
Net cash provided by operating activities.............................................................. 2,412,000
Cash flows from investing activities
Additions to property and equipment......................................................................... (497,000)
Net cash used by investing activities...................................................................... (497,000)
Cash flows from financing activities
Proceeds from long-term debt............................................ ......................................... 300,000
Repayment of long-term debt ...................................................................................... (299,000)
Net cash provided (used) by financing activities................................................ 1,000
Net increase in cash and temporary cash investments .............................................. 1,916,000
Beginning cash and temporary cash investments......................................................... 1,021,000
Ending cash and temporary cash investments..............................................................$ 2,937,000
Reconciliation of Income From Operations to Net Cash Provided
by Operating Activities
Income from operations................................................................................................. 1,218,000
Adjustments to reconcile income from operations to net cash provided by
operating activities
Depreciation and amortization................................................................................. 370,000
Increase in accounts payable—medical services................................................... 774,000
Increase (decrease) in unearned premium revenue................................................... (61,000)
Decrease in premiums receivable 49,000
Net effect of changes in other receivables, supplies, prepaid expenses, and
other payables................................................................................................................. 62,000
Net cash provided by operating activities......................................................... $ 2,412,000
19X4
$ 24,410,000 
(22,818,000)
90,000
(372,000)
1,310,000
(121,000)
(121,000)
(1,000,000)
(1,000,000)
189,000
832,000
$ 1,021,000
590,000
339,000
335,000
115,000
84,000
(153,000) 
$ 1,310,000
See accompanying notes to financial statements.
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SAMPLE HEALTH MAINTENANCE ORGANIZATION
.24 Notes to Financial Statements
June 30, 19X5 and 19X4
1. Formation and Purpose
Sample Health Maintenance Organization (Sample HMO) was incorporated in 19X0 as a not-for-profit 
corporation for the purpose of providing comprehensive health care services on a prepaid basis and for the 
purpose of establishing and operating organized health maintenance and health care delivery systems.
Sample HMO has been determined to be a qualified health maintenance organization (HMO) under Title XIII 
of the Public Health Service Act.
2. Summary of Significant Accounting Policies 
Temporary cash investments
Temporary cash investments at June 30, 19X5 and 19X4, include a repurchase agreement with a bank and 
certificates of deposit with original maturities of less than ninety days carried at a cost that is equivalent to 
market.
Premiums revenue
Membership contracts are on a yearly basis subject to cancellation by the employer group or Sample HMO 
upon thirty days written notice. Premiums are due monthly and are recognized as revenue during the period 
in which Sample HMO is obligated to provide services to members.
Health care service cost recognition
Sample HMO contracts with various health care providers for the provision of certain medical care services to 
its members. Sample HMO compensates those providers on a capitation basis. As part of a cost control 
incentive program, Sample HMO retains up to XX percent of the capitation as a risk-sharing fund. In the 
event of hospital utilization in excess of budget, those providers bear the risk to the extent of XX percent of the 
capitation fee. Operating expenses include all amounts incurred by Sample HMO under the aforementioned 
contracts.
The cost of other health care services provided or contracted for is accrued in the period in which it is 
provided to a member based in part on estimates, including an accrual for medical services provided but not 
reported to Sample HMO.
Inventories of supplies
Inventories of drugs and other supplies are stated at the lower of cost (first-in, first-out) or market.
Property and equipment
Property and equipment are recorded at cost, less accumulated depreciation. Maintenance and repairs are 
charged to expense, and betterments are capitalized. Property and equipment costing approximately $700,000 
was financed by initial development grants received in 19X1 and 19X2 from the U.S. Department of Health 
and Human Services. This property will be owned by Sample HMO as long as the equipment and facilities 
are used for projects related to the objectives of the Public Health Service Act.
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Depreciation is computed using the straight-line method over the estimated useful lives of the related assets 
as follows:
Building............................................................................................................................................. 40 years
Improvements.................................................................................................................................. 20-25 years
Data processing and laboratory equipment and automobiles.............................................. 3-7 years
Medical equipment......................................................................................................................... 10 years
Office equipment........................................................................................................................... 5-10 years
Amortization of debt issuance costs
Debt issuance costs are deferred and amortized using the interest method over the term of the related debt.
Retirement plan expense
Sample HMO has a retirement plan as more fully described in note 6. Charges to expenses are recognized 
when Sample HMO makes contributions to the plan.
Federal income tax
Sample HMO is exempt from federal income taxes under Section 501(c)(4) of the Internal Revenue Code; 
accordingly, no provision for federal income taxes has been made in the accompanying financial statements.
Reinsurance (stop-loss insurance)
Reinsurance premiums are reported as health care costs, and reinsurance recoveries are reported as revenue.
3. Property and Equipment
19X5 19X4
Property and equipment at June 30, 19X5 and 19X4, consists of the following:
Land................................................................................... ..................................... $ 300,000 $ 300,000
Buildings and improvements........................................ ..................................... 5,473,000 5,459,000
Furniture and equipment.............................................. ..................................... 1,786,000 1,303,000
7,559,000 7,062,000
Less accumulated depreciation................................... ..................................... 1,803,000 1,436,000
$5,756,000 $5,626,000
4. Long-Term Debt
Long-term debt is collateralized by assets with a depreciated cost at June 30, 19X5, of $4,943,000. A summary 
of long-term debt at June 30, 19X5 and 19X4, follows.
19X5 19X4
HHS loan, interest at 7.5%................................................... ...............................$2,020,000 $2,111,000
HHS loan, interest at 9.25%................................................ ............................... 1,658,000 1,694,000
Secured equipment loans..................................................... ............................... 858,000 686,000
4,536,000 4,491,000
Less portion payable within one year............................... ............................... 241,000 109,000
$4,295,000 $4,382,000
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Scheduled principal payments on long-term debt are as follows:
Fiscal Year
Scheduled Principal 
Payments
19X6
19X7
19X8
19X9
19Y0
.............................................................................................................................................$ 241,000
............................................................................................................................................. 259,000
............................................................................................................................................. 280,000
............................................................................................................................................. 800,000
............................................................................................................................................. 2,956,000
$4,536,000
5. State Guarantee Fund Deposit
In August 19X5 the state in which Sample HMO is domiciled enacted legislation specifically governing 
HMOs. Under this legislation, Sample HMO is required to maintain a deposit of $150,000 with the director of 
the division of insurance of the state.
6. Employee Retirement Plan
Sample HMO has a contributory defined contribution retirement plan covering substantially all employees. 
Expense determined in accordance with the plan formula (4 percent to 10 percent of eligible covered 
compensation) was $354,000 for the year ended June 30, 19X5 ($275,000 for 19X4).
7. Stop-loss Insurance
Sample HMO has entered into a stop-loss insurance agreement with an insurance company to limit its losses 
on individual claims. Under the terms of this agreement, the insurance company will reimburse Sample HMO 
approximately XX percent of the cost of each member's annual hospital services, in excess of a $XXX 
deductible, up to a lifetime limitation of $XXX per member. In the event Sample HMO ceases operations, (a) 
plan benefits will continue for members who are confined in an acute care hospital on the date of insolvency 
until their discharge and (b) plan benefits will continue for any other member until the end of the contract 
period for which premiums have been paid.
Stop-loss insurance premiums of approximately $700,000 and $500,000 are included in health care costs in 
19X5 and 19X4, respectively. Approximately $600,000 and $400,000 of stop-loss insurance recoveries are 
deducted from health care costs in 19X5 and 19X4, respectively.
Included in other receivables is approximately $50,000 recoverable from insurers.
8. Malpractice Claims
Malpractice claims have been asserted against Sample HMO by various claimants. The claims are in various 
stages of processing, and some may ultimately be brought to trial. In the opinion of counsel, the outcome of 
these actions will not have a significant effect on the financial position, results of operations or cash flows of 
Sample HMO. Incidents occurring through June 30, 19X5, may result in the assertion of additional claims. 
Other claims may be asserted arising from past services provided. Management believes that these claims, if 
asserted, would be settled within the limits of insurance coverage.
9. Concentrations of Credit Risk
[The disclosures contained in this note would be similar to the disclosures contained in note 15 of Sample 
Hospital.]
81
SAMPLE AMBULATORY CARE, INC.
.25 Balance Sheets
December 31, 19X5 and 19X4
Assets 19X5 19X4 Liabilities and Fund Balance 19X5 19X4
Current assets Current liabilities
Cash........................................$
Patient accounts receivable
65,000 $ 76,000 Notes payable (note 3) .... $ 138,000 $ 144,000
less allowance for 
uncollectible accounts
19X5—$15,000; 19X4— 
$5,000 ................................. 290,000 278,000 Accounts payable..................
Accrued payroll, benefits,
52,000 87,000
and taxes............................. 33,000 22,000
Estimated retroactive Estimated retroactive
adjustments—third-party adjustments—third-party
payors (note 4).................. 19,000 32,000 payors (note 4)..................
Financing advance from
30,000 24,000
third-party payor............. — 1,000
Accounts receivable—other 13,000 8,000 Total current liabilities... 253,000 278,000
Supplies.................................
Prepaid expenses and
deposits...............................
21,000 18,000
5,000 9,000
Total current assets......... 413,000 421,000
Property and equipment, at cost
Land.....................................
Land improvements.........
Buildings...............................
Equipment..........................
. 100,000 
322,000 
682,000
. 1,390,000
100,000
322,000
682,000
1,389,000
Less accumulated 
depreciation....................
2,494,000
217,000
2,493,000
100,000
Net property and 
equipment ...................... . 2,277,000 2,393,000 Commitment (note 5)........... — —
Advances receivable (note 5) 14,000 5,000 Fund balance.......................... .. 2,451,000 2,541,000
Total assets...................... . $2,704,000 $2,819,000
Total liabilities and fund 
balance............................ .. $2,704,000 $2,819,000
See accompanying notes to financial statements.
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SAMPLE AMBULATORY CARE, INC.
26 Statements of Revenue and Expenses and Changes in Fund Balances 
Years Ended December 31, 19X5 and 19X4
Net patient service revenue (note 7) .............................................................
Operating gains...................................................................................................
Total operating revenue and gains.....................................................
Expenses
Salaries and wages 
Employee benefits
Supplies ...............
Purchased services
Insurance .............
Professional fees..
Interest ..................
Depreciation.........
Total expenses ........................................................................................
Loss from operations.............................................................................
Nonoperating gain—interest income..............................................................
Expenses in excess of revenue and gains..........................................
Fund balance at beginning of period.............................................................
Fund balance at end of period ........................................................................
19X5
$ 860,000
26,000
886,000
425,000
77,000
107,000
177,000
34,000
27,000
15,000
117,000
979,000
(93,000)
3,000
(90,000)
2,541,000
$2,451,000
19X4
$ 357,000 
14,000 
371,000
184,000
54,000
52,000
109,000
22,000
1,000
17,000
100,000
539,000
(168,000)
11,000
(157,000)
2,698,000
$2,541,000
See accompanying notes to financial statements.
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SAMPLE AMBULATORY CARE, INC.
.27 Statements of Cash Flows
Years Ended December 31, 19X5 and 19X4
19X5 19X4
Cash flows from operating activities and gains
Cash received from patients and third-party payors...................................................$ 866,000 $ 368,000
Cash received from others................................................................................................. 21,000 6,000
Interest received.................................................................................................................. 3,000 11,000
Interest paid........................................................................................................................... (15,000) (16,000)
Cash paid to employees and suppliers........................................................................... (870,000) (432,000)
Net cash provided from (used for) operating activities and gains.................... 5,000 (63,000)
Cash flows from investing activities
Purchase of equipment....................................................................................................... (1,000) (4,000)
Advances made.................................................................................................................... (9,000) (5,000)
Net cash used for investing activities...................................................................... (10,000) (9,000)
Cash flows from financing activities
Proceeds from notes payable............................................................................................ — 144,000
Payments on notes payable.............................................................................................. (6,000) —
Net cash provided from (used for) financing activities ..................................... (6,000) 144,000
Net increase (decrease) in cash............................................................................................ (11,000) 72,000
Cash at beginning of year....................................................................................................... 76,000 4,000
Cash at end of year.................................................................................................................. $ 65,000 $ 76,000
Reconciliation of Expenses in Excess of Revenues and Gains to Net Cash Provided 
From (Used For) Operating Activities and Gains
Net Loss (90,000) (157,000)
Adjustments to reconcile expenses in excess of revenues and gains to net cash 
provided from (used for) operating activities and gains
Depreciation ......................................................................................................................... 117,000 100,000
Provision for bad debts....................................................................................................... 14,000 4,000
Net increase in receivables and net third-party payor adjustments........................ (12,000) (19,000)
Net decrease (increase) in inventories of supplies, prepaid expenses and
deposits ............................................................................................................................. 1,000 (2,000)
Net increase (decrease) in accounts payable, accrued expenses and advances
from Blue Cross................................................................................................................ (25,000) 11,000
Net cash provided from (used for) operating activities and gains........................ $ 5,000 $ (63,000)
See accompanying notes to financial statements.
84
SAMPLE AMBULATORY CARE, INC.
.28 Notes to Financial Statements
December 31, 19X5 and 19X4
1. Summary of Significant Accounting Policies 
Net patient service revenue
Patient service revenue is reported at the estimated net realizable amounts from patients, third-party payors, 
and others for services rendered.
Third-party contractual adjustments
Retroactively calculated third-party contractual adjustments are accrued on an estimated basis in the period 
the related services are rendered. Net patient service revenue is adjusted as required in subsequent periods 
based on final settlements.
Charity care
Sample Ambulatory Care, Inc. has a policy of providing charity care to patients who are unable to pay. Such 
patients are identified and related charges are estimated, based on financial information obtained from the 
patient and subsequent analysis. Since management does not expect payment for charity care, the estimated 
charges are excluded from revenue.
Supplies
Supplies are stated at the lower of cost (first-in, first-out) or net realized value.
Depreciation
Depreciation of property and equipment is computed on the straight-line method over the estimated lives of 
depreciable assets.
Investment income
Investment income and gains on investment transactions are recorded as nonoperating revenue.
2. Formation and Scope of Operations
Sample Ambulatory Care, Inc. was incorporated on September 7, 19X3, to operate an ambulatory care health 
facility to treat or prevent injury and disease, to provide funds or to expend funds to further the treatment or 
prevention of injury or disease, and to develop and participate in activities designed to promote the general 
health of the community.
Three area hospitals—ABC Hospital and Health Center, DEF Hospital, and GHI Hospital—entered into a 
members' agreement to develop this ambulatory care center. In accordance with this agreement, each hospital 
contributed capital of $947,000 to Sample Ambulatory Care, Inc.
Sample Ambulatory Care, Inc. began operations in October 19X3.
3. Related Party Transactions
During 19X3, Sample Ambulatory Care, Inc. entered into a contract with one of the member hospitals 
(managing hospital) for the management of the business and affairs of Sample Ambulatory Care, Inc. Under 
this agreement, Sample Ambulatory Care, Inc. pays $4,000 per month to the managing hospital. The
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agreement with the managing hospital was to remain in effect through December 31, 19X5, but has been 
extended on a month-to-month basis.
In addition, during 19X4, each hospital loaned $48,000 to Sample Ambulatory Care, Inc. in the form of 
promissory notes at an interest rate of prime plus one percent (effective rates of 10 percent and 9 percent in 
19X5 and 19X4, respectively). Of the total $144,000 liability, $48,000 is payable on demand after November 
28,19X5, to one member hospital, with the remaining portion ($96,000) payable on demand after December 
8, 19X5, to the other two member hospitals. During 19X5, Sample Ambulatory Care, Inc. paid $2,000 to each 
member hospital, thereby reducing the obligation to $138,000
4. Revenue From Contracting Agencies
Sample Ambulatory Care, Inc. participates as provider of health care services to Blue Cross, Medicare, and 
County Indigent Plan patients. Reimbursement for covered services is based on tentative payment rates. Final 
reimbursement rates are determined after submission of annual cost reports and audits thereof by the fiscal 
intermediaries. Provisions for estimated reimbursement adjustments are reported in the financial statements 
in the period that the services are rendered.
5. Advances Receivable
In May 19X4 Sample Ambulatory Care, Inc. entered into a five-year agreement with XYZ Affiliates (XYZ). 
Under this agreement, XYZ is to provide emergency medical services as well as charge and bill each patient 
treated at Sample Ambulatory Care, Inc. Sample Ambulatory Care, Inc. has guaranteed that XYZ will collect 
at least $18,000 per month during the term of this agreement. In any month in which XYZ does not collect the 
minimum guarantee, Sample Ambulatory Care, Inc. advances funds to XYZ to cover the deficiency. Such 
advances are to be repaid to the extent XYZ's net cash collections exceed the minimum guarantee amount. 
Management estimates that the advances will be fully recovered in 19X6.
6. Income Taxes
Sample Ambulatory Care, Inc. is a not-for-profit corporation as described in Section 501(c)(3) of the Internal 
Revenue Code and is exempt from federal income taxes on related income pursuant to Section 501(a) of the 
Code.
7. Charity Care
Sample Ambulatory Care, Inc. has a policy of providing charity care to indigent patients in emergency 
situations. These services, which are excluded from revenues, amounted to $27,000 and $13,000 in 19X3 and 
19X4, respectively, when measured at Sample Ambulatory Care, Inc's established rates.
8. Concentrations of Credit Risk
[The disclosures contained in this note would be similar to the disclosures contained in note 15 of Sample 
Hospital.]
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